About Us

Page 21234..1020..»

Global Virtual Reality in Medicine and Healthcare Market Top Players 2026: Google, Orca Health, Brain Power, Medsights Tech, AccuVein etc. – The Think…

Posted: October 18, 2020 at 12:53 am

This versatile research report on Global Virtual Reality in Medicine and Healthcare Market entails details on the most popular trends, further suggesting the upcoming ones as well as concomitant consumer reactions pertaining to holistic growth in global Virtual Reality in Medicine and Healthcare market.

The report also sheds ample light on the competitive landscape with versatile details on vendor positioning as well as their activities that remain indispensable growth catalysts.

Besides presenting a detailed synopsis of the current market scenario, this section of the report also includes versatile details on the overall ecosystem, key trends, market catalysts as well as threats and challenges that seem to significantly impact revenue generation in the Virtual Reality in Medicine and Healthcare market.

which market players and aspiring new entrants may witness seamless entry.

GoogleOrca HealthBrain PowerMedsights TechAccuVeinMicrosoftEchoPixelAugmedixAtheerAira

Frequently Asked Questions: Global Virtual Reality in Medicine and Healthcare Marketo In terms of product and application based segmentation, which segment is likely to remain most promising?o Based on concurrent developments, which trends are likely to remain most dominant through the forecast span?o Considering the pandemic crisis and other associated alterations, what could be the most relevant market projections?

o Who would continue to remain atop the growth curve in global Virtual Reality in Medicine and Healthcare market through the forecast years?

o What are the top threats and challenges identified in the Virtual Reality in Medicine and Healthcare market?

Find full report and TOC here: @ https://www.orbisresearch.com/reports/index/global-virtual-reality-in-medicine-and-healthcare-market-size-status-and-forecast-2020-2026?utm_source=PoojaM

Further in the course of the report, readers are also aided in identifying high potential segment across Virtual Reality in Medicine and Healthcare market and its caliber in instilling revenue maximization and profit development. Subsequent sections of the report also include details on product and service types as well as their associated application scope.

The market is roughly segregated into:

Segmentation by Type


Segmentation by Application

HospitalClinicMedical Research CenterOther

Segmentation by Region with details about Country-specific developments North America (U.S., Canada, Mexico) Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) Latin America (Brazil, Rest of L.A.) Middle East and Africa (Turkey, GCC, Rest of Middle East)

This report besides representing detailed synopsis of the current market scenario, this section of the report also includes versatile details on the overall ecosystem, key trends, market catalysts as well as threats and challenges that seem to significantly impact revenue generation in the Virtual Reality in Medicine and Healthcare market. Post persistent observation and research initiatives, this new research presentation on global Virtual Reality in Medicine and Healthcare market has been recently released to ensure optimum scavenging of the global Virtual Reality in Medicine and Healthcare market to make vital conclusions.

Tracing Recovery Journey: COVID-19 Apart from gauging into the present as well as future implications of COVID, the report is a dependable document to understand the dormant opportunities, new products and services that are likely to be more relevant in post COVID-19 market. This section of the report therefore shares vital details and workable cues on new product profiles to help businesses revive from the COVID aftermath. This intensively researched report presentation has been prepared in real time parlance, rendering substantial attention towards COVID-19 outbreak that has lately wrecked unprecedented damage across industries, stagnating growth. The report lends attention towards evaluating the Virtual Reality in Medicine and Healthcare market in terms of exhaustive research in the times of COVID, as well as devising appropriate come back protocols to restore normalcy.

Primary Purpose of the Report The report follows a top down investigative approach to unravel forecast projections The report presents a thorough investigative study of the Virtual Reality in Medicine and Healthcare market to assist and guide profitable business discretion This high-end research report representation on the Virtual Reality in Medicine and Healthcare market is fundamentally aimed to unravel developments such as supply and demand scenario Further, the report scouts further analysis to identify and group the eventful developments, sectioning them in fragments and categories to direct profit ventures in the Virtual Reality in Medicine and Healthcare market, also aiding market participants business discretion

Relevant details on prevalent market competition and rising intensity with inclusion of new market players also find ample mention in the report to evoke wise comprehension and appropriate growth related business strategies, favoring strong competitive edge. Details on technological innovation, and inputs on M&A developments, commercial agreements have all been touched upon in this illustrative research report on the Virtual Reality in Medicine and Healthcare market.

Do You Have Any Query or Specific Requirement? Ask Our Industry [emailprotected] https://www.orbisresearch.com/contacts/enquiry-before-buying/4218232?utm_source=PoojaM

DROT Review and Analysis: Global Virtual Reality in Medicine and Healthcare Market

Drivers: This information report proceeds with unearthing the various growth propellants that harness optimum growth in global Virtual Reality in Medicine and Healthcare market

Barrier Analysis: The report is also committed to adequately gauge for ample threats and challenges that collectively drive high end rise in global Virtual Reality in Medicine and Healthcare market.

Opportunity Analysis: Finally, this report also tilts towards identifying offbeat market opportunities even amidst the odds and catastrophes to ensure tremendous transformation in global Virtual Reality in Medicine and Healthcare market.

Customization Service of the Report:-Orbis Market Reports Analysis gives customization of Reports as you want. This Report will be customized to satisfy all of your necessities. For those who have any query get in contact with our sales staff, who will assure you to get a Report that fits your requirements.

Looking for provoking fruitful enterprise relationships with you!

About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Read the rest here:
Global Virtual Reality in Medicine and Healthcare Market Top Players 2026: Google, Orca Health, Brain Power, Medsights Tech, AccuVein etc. - The Think...

Mark Hyman, the ‘Dr. Oz’ of Nutrition, Says Food Is Killing People Like the Holocaust – American Council on Science and Health

Posted: October 15, 2020 at 5:59 pm

It's difficult to out-Oz Dr. Oz, America's Quack, who has raked in giant piles of money by promoting pseudoscience on his TV show. But at least one person comes perilously close: Dr. Mark Hyman.

Hyman is the "Dr. Oz" of nutrition. He embraces legitimate science if and only if it suits his bottom line. Otherwise, he's promoting junk science and magical thinking. To get an idea of the sort of nonsense that he spews, his website features an interview with the Food Babe, as well as his infuriatingly stupid quote, "Food isn't like medicine, it is medicine." The comma splice just makes me that much angrier.

The Many Lies of Dr. Mark Hyman

Hyman made a recent appearance on the Rubin Report, which is hosted by conservative commentator Dave Rubin. Hyman took the inadvisable step of taking a cheap shot at ACSH, so we thought we would reciprocate by fact-checking some of the interview. (Note: The interview is 55 minutes long, and my head would explode if I actually listened to all of it.) Buckle up.

"I became a doctor and kind of got indoctrinated, literally, and became very focused on traditional, good medicine, but I realized the limits of it. And then I got sick myself and ended up having to fix myself using functional medicine.

Wow, the bullsh** is strong with this one. He claims that doctors are being force-fed lies in medical school and that the real truth is what he calls "functional medicine" -- which is just a different term for alternative medicine, holistic medicine, integrative medicine, or whatever rainbow-and-unicorn term these quacks prefer. I generally frown upon Wikipedia, but the first sentence in its entry on Functional Medicine is too good to pass up: "Functional medicine is a form of alternative medicine that encompasses a number of unproven and disproven methods and treatments."

Six out of ten Americans have a chronic disease. It kills 11 million people a year from food.

Huh?! His first statistic is true, but the second is a gigantic, whopping lie. (See figure taken from the CDC.) Considering that chronic disease includes everything from heart disease to Alzheimer's, there's a lot of territory to cover. Poor nutrition is simply one risk factor among many. Other risk factors are genetic or environmental. So, to single out food as the primary cause of chronic illness is just plain wrong.

Also, I have no idea where he gets his statistic that 11 million people die from food every year. Each year, about 2.8 million Americans die from all causes. Globally, there are about 56 million deaths from all causes. Hyman just fabricated the 11 million number, which he then refers to as "like a Holocaust" (at the 6:00 mark). Twinkies, Nazis? Basically the same thing.

"If I really want to cure my patients, I have to step back and look at the big picture of what's wrong with our food system, the impact it's causing on disease, on our economy, on social justice issues, poverty, mental health, kids' academic performance, national security, environment, climate. It's all one problem that is predominantly driven by our food."

Food is not the root cause of national security problems, let alone every other problem on the planet. Hyman sounds like that guy from The History Channel who blames everything on aliens. Anytime somebody fingersa singleboogeyman for causing every disease and problem known to mankind, this is a giant red flag indicating quackery.

"Most states have obesity rates over 40%."

Obesity is a substantial problem in this country, but this is another made-up statistic. Only one state (Mississippi) has an obesity rate over 40%, according to the CDC.

"We have one in three federal dollars that are spent on Medicare."

Yet another made-up statistic. Here are the federal outlays for 2019:

Medicare cost $644 billion. With $4.4 trillion in spending, that means the federal government spent about 15% of its budget (roughly 1 in 7 dollars) on Medicare. If we're generous and include Medicaid, that is 24% of the budget (about 1 in 4 dollars). Again, Hyman just fabricates numbers out of thin air. To add yet more absurdity, Hyman claimed a moment later that 80% of the spending is unnecessary because it's caused by food. Right, if only everybody ate broccoli everyday, nobody would have cancer or dementia.

(I'm now merely 7 minutes and 25 seconds into the video, and I simply can't take anymore of this. So let's fast forward to the point where he takes a swipe at ACSH. It begins at 13:00.)

"They create front groups... to confuse consumers saying, for example, that pesticides and high fructose corn syrup and trans fats and smoking are not bad for you, like the American Council on Science and Health."

By "they," I think Hyman is referring to aliens food companies. Anyway, Hyman is lying again. ACSH has always been anti-smoking. Always. In regard to trans fats, we're sort of ambivalent on the issue. Dr. Chuck Dinerstein wrote in 2018 that the FDA has largely eliminated trans fats from the American diet, but there doesn't seem to be much of an impact on cardiovascular disease. Pesticides are safe if used at appropriate doses (which they are). (Besides, plants make 99.99% of the pesticides we consume.) And when analyzed chemically, high fructose corn syrup is basically honey.

Don't ever listen to Mark Hyman.

See more here:
Mark Hyman, the 'Dr. Oz' of Nutrition, Says Food Is Killing People Like the Holocaust - American Council on Science and Health

Why are essential vitamins and botanicals continue to be overlooked? – Modern Ghana

Posted: at 5:59 pm

Recently on 60 minutes to be accessed at here, reported on the lasted news on COVID-19, which included President Trump's cocktail of medications. The segment heavily focused on auto-antibody treatment by two companies producing and studying such drugs, Regeneron (the other company is Eli Lily). I was disappointed not to hear one bit of information on President Trump's other over-the-counter substances, including vitamin D, zinc, and Melatonin. Not one!

Interesting, according to another report to be accessed at https://www.insider.com/fauci-takes-recommends-vitamin-d-and-c-supplements-immunity-boost-2020-9. Though Dr. Fauci is also taking vitamin D and C, these powerful nutrients are overlooked! Per the report, Dr. Anthony Fauci, a leading US expert in infectious disease, said in a recent interview that he took vitamin D and C supplements to keep a healthy immune system. There's good science behind his recommendation, with plenty of evidence that being deficient in either nutrient can make you more susceptible to infection. Fauci said most other immune-boosting claims, however, are useless. There's little evidence other supplements make much difference in preventing illness.

So the question still remains: why are essential Vitamins and Herbal Medicines continue to be overlooked?

Well, people keep asking me this important question which I do not have control over them. Well, I don't get into these types of discussions much. I focus on what I can control and apply science-based information to help patients, myself, and my family. Yes, of course, money and politics are always involved here. Despite the sometimes high cost of dietary supplements, that is a dearth of what pharmaceutical drugs cost say Dr. Geo Espinoza. A single dose of Trump's regimen, which would include Regeneron auto-antibodies, Remdemsivir, and others, would cost an upwards of $5000. Just for one, single dose. However, if you were only to take just one essential vitamin, Vitamin D is $15 to $20 a bottle, says, Espinoza.

Why Vitamin D?

Vitamin D is vital for a healthy immune system and according to Martineau et al 2017. It helps

prevent respiratory infections. Vitamin D deficiency increases the risk of COVID infection, Meltzer et al 2020. There's evidence to support supplementing vitamin D and C for immune health.

Extensive evidence by Rondanelli, et al 2018 has linked vitamin D deficiency to greater risk of infection, particularly from respiratory diseases like COVID-19.

That's led many researchers to investigate the use of vitamin D supplements to help prevent or lessen the effects of the coronavirus. While the findings are somewhat contentious, since researchers don't fully understand if vitamin D supplements can cause better health outcomes, studies have consistently linked vitamin D deficiency to greater risk of severe infection to be accessed at https://www.insider.com/new-reports-evidence-on-vitamin-d-and-coronavirus-2020-7. And many people are deficient in vitamin D, especially while sheltering indoors during the pandemic or in darker winter months, since our bodies naturally produce the nutrient in response to sunlight, to be accessed at https://www.insider.com/vitamin-d-deficiency-raises-coronavirus-covid-risk-study-2020-9. People with darker skin may be particularly susceptible, since melanin can slow the process of producing vitamin D. As a result, there's evidence certain people could benefit from supplementing it. The standard recommendation is to take 4000 to 5000 units a day with food or something fatty like fish oil. Vitamin D is fat-soluble.

Why Zinc?

Zinc is essential for a strong immune system to be accessed at https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/#h3 and offers resistance to infections according to Shankar and Prasad, 1998, People with COVID-19 who also had low zinc levels, developed worse outcome from the coronavirus, Dinesh et al 2020.

The recommended dosage is to take 15 to 30mg of zinc, once to two times daily. Taking 60 mg of zinc a day for a long time may require at least one to two mg of Copper to avoid copper deficiency.

Why Melatonin?

You heard Trump was given Melatonin as well? Melatonin is a hormone released at night, during sleep and a very dark environment by the brain's area called the pineal gland. According to research by Huang et la 2019, Melatonin possess an anti-influenza potential through immune modulatory effect. Recently, according to research by Juybari et al 2020,Melatonin has shown potential anti-COVID properties. Per recommendation, in dietary supplements, 3 mg - 30 to 60 minutes before bedtime is a good amount to take. Melatonin may or may not help with getting a restful sleep in my experience (about 50/50), but it may still have good immune benefits, says Dr. Espinoza. Dr. Espinoza, questions why, President Trump does not seem to be taking vitamin C, selenium, and other potent anti-viral botanicals.

Botanicals helpful for immune and anti-viral purposes

Medicinal herbs with anti-viral properties and essential for immunity include curcumin, elderberries, Andrographis, goldenseal, Echinacea, Astragalus, and Arabinogalactan (Larch tree).


Elderberry: Benefits and Dangers

One study for instance conducted by researchers posits that Elderberry compounds could help minimize flu symptoms, study suggests, to be accessed at https://www.sciencedaiily. Per the study by Torabian et al 2019, Compounds from elderberries can directly inhibit the virus's entry and replication in human cells, and can help strengthen a person's immune response to the virus. study by a group of Chemical and Biomlolecular Engineering researchers from the University of Sydney's Faculty of Engineering and IT has determined exactly how a popular ancient remedy, the elderberry fruit, can help the fight against influenza.

Conducted by Professor Fariba Deghani, Dr Golnoosh Torabian and Dr Peter Valtchev as part of the ARC Training Centre for the Australian Food Processing Industry that was established in the Faculty of Engineering and IT, the study showed that compounds from elderberries can directly inhibit the virus's entry and replication in human cells, and can help strengthen a person's immune response to the virus. Although elderberry's flu-fighting properties have long been observed, the group performed a comprehensive examination of the mechanism by which phytochemicals from elderberries combat influenza infections.

"What our study has shown is that the common elderberry has a potent direct antiviral effect against the flu virus," said Dr Golnoosh Torabian. "It inhibits the early stages of an infection by blocking key viral proteins responsible for both the viral attachment and entry into the host cells."

The researchers used commercially farmed elderberries which were turned into a juice serum and were applied to cells before, during and after they had been infected with the influenza virus.

The phytochemicals from the elderberry juice were shown to be effective at stopping the virus infecting the cells, however to the surprise of the researchers they were even more effective at inhibiting viral propagation at later stages of the influenza cycle when the cells had already been infected with the virus.

"This observation was quite surprising and rather significant because blocking the viral cycle at several stages has a higher chance of inhibiting the viral infection," explained Dr Peter Valtchev.

"In addition to that, we identified that the elderberry solution also stimulated the cells to release certain cytokines, which are chemical messengers that the immune system uses for communication between different cell types to coordinate a more efficient response against the invading pathogen," said Centre Director, Professor Fariba Deghani.

The team also found that the elderberry's antiviral activity can be attributed to its anthocyanidin compounds -- phytonutrients responsible for giving the fruit its vivid purple colouring.

Otherwise known as sambucus nigra, the black elderberry is a small, antioxidant rich fruit common to Europe and North America that is still commonly consumed as a jam or wine. For medicinal benefits, elderberry extract is available commercially in tablet or syrup form. The influenza virus is one of the leading causes of mortality worldwide, affecting nearly 10 per-cent of the world population and contributing to one million deaths annually.

Another study by Block et al 2003 titled Immune system effects of echinacea, ginseng, and astragalus: a review revealed that Cancer patients may wish to use these botanicals to inhibit tumor growth or to boost resistance to infections. However, passive immunotherapy with herbs, with no mechanism to expose tumor antigens, is unlikely to be effective in inhibiting tumor growth.


11 Herbs You Need to Know for Immune Support: Gaia Herbs

According to Qin et al 2012, Astragalus Membranaceus extract activates immune response in macrophages via heparanase. Additionally , there hundreds of research studies to support this important herbs.



Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials. Dion et al 2016 provided the answer. Their study review the immunomodulatory effects of larch arabinogalactan derived from Larix laricina and Larix occidentalis (North American Larix species) and more specifically its role in the resistance to common cold infections. In cell and animal models, larch arabinogalactan is capable of enhancing natural killer cells and macrophages as well as the secretion of pro-inflammatory cytokines. In humans a clinical study demonstrated that larch arabinogalactan increased the bodys potential to defend against common cold infection. Larch arabinogalactan decreased the incidence of cold episodes by 23 %. Improvements of serum antigen-specific IgG and IgE response to Streptococcus pneumoniae and tetanus vaccination suggesting a B cell dependent mechanism have been reported in vaccination studies with larch arabinogalactan, while the absence of response following influenza vaccination suggests the involvement of a T cell dependent mechanism. These observations suggest a role for larch arabinogalactan in the improvement of cold infections, although the mode of action remains to be further explored. Different hypotheses can be envisaged as larch arabinogalactan can possibly act indirectly through microbiota-dependent mechanisms and/or have a direct effect on the immune system via the gut-associated lymphoid tissue (GALT).


Echinacea for Colds: Does It Work?

A study conducted by Zhai et al 2006 titled Enhancement of Innate and Adaptive Immune Functions by Multiple Echinacea Species involves alcohol extracts from three widely used Echinacea species, Echinacea angustifolia, Echinacea pallida, and Echinacea purpurea, were investigated for immunomodulating properties. Taken together, these findings demonstrated that Echinacea is a wide-spectrum immunomodulator that modulates both innate and adaptive immune responses. In particular, E. angustifolia or E. pallida may have more anti-inflammatory potential.


My herb of choice which is part of my Mens Formula Tea formulated for Prostate Health and Wellness. A study conducted by Abdollahi et al 2017 titled Therapeutic effects of curcumin in inflammatory and immunemediated diseases: A naturemade jackofalltrades?. Novel animal and human studies indicate that curcumin can affect different immune cells, such as various T lymphocyte subsets, macrophages, dendritic cells, B lymphocytes and natural killer cells, which results in decreasing severity of various diseases with immunological etiology. The review provides a comprehensive overview of the effects of curcumin on different immune cells and immune systemrelated diseases.

What should you do?

I've recommended a few items to support immune function and have anti-viral benefits.

Get yourself zinc, vitamin D, selenium, vitamin C and Melatonin from any source; these are essential.

The most important thing you can do is keep your body strong during the coronavirus pandemic. Exercise, eat well, get good sleep, and take the right dietary supplements and correct formulated botanicals such as the Mens Formula for prostate Health, Nyarkotey Hibiscus Tea for Cardiovascular support and Womens Formula for wellness.

DISCLAIMER: This post is for enlightenment purposes only and should not be used as a replacement for professional diagnosis and treatments. Remember to always consult your healthcare provider before making any health-related decisions or for counselling, guidance and treatment about a specific medical condition.

NB: The writer is on a mission to provide you and your family with the highest quality nutrition tips, scientific herbs and healthy recipes in the world.

The writer is an honorary Professor of Holistic Medicine-Vinnytsia State Pedagogical University, Ukraine, president, Nyarkotey College of Holistic Medicine and currently, LLB law/MBA Student. He is the formulator of FDA approved Nyarkotey Hibiscus Tea for Cardiovascular Support and wellness, Mens Formula for Prostate Health and Womens Formula for wellness. Contact: 0241083423/0541234556


i. Rondanelli, M., Miccono, A., Lamburghini, S., Avanzato, I., Riva, A., Allegrini, P., Faliva, M. A., Peroni, G., Nichetti, M., & Perna, S. (2018). Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evidence-based complementary and alternative medicine : eCAM, 2018, 5813095. https://doi.org/10.1155/2018/5813095sss

ii. Martineau Adrian R, Jolliffe David A, Hooper Richard L, Greenberg Lauren, Aloia John F, Bergman Peter et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data BMJ 2017; 356 :i6583

iii. Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2020;3(9):e2019722. doi:10.1001/jamanetworkopen.2020.19722

iv. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998 Aug;68(2 Suppl):447S-463S. doi: 10.1093/ajcn/68.2.447S. PMID: 9701160

v. Bahrampour Juybari, K., Pourhanifeh, M. H., Hosseinzadeh, A., Hemati, K., & Mehrzadi, S. (2020). Melatonin potentials against viral infections including COVID-19: Current evidence and new findings. Virus research, 287, 198108. https://doi.org/10.1016/j.virusres.2020.198108

vi. Golnoosh Torabian, Peter Valtchev, Qayyum Adil, Fariba Dehghani. Anti-influenza activity of elderberry (Sambucus nigra). Journal of Functional Foods, 2019; 54: 353 DOI: 10.1016/j.jff.2019.01.031

vii. Block KI, Mead MN. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther. 2003 Sep;2(3):247-67. doi: 10.1177/1534735403256419. PMID: 15035888

viii. Qin Q, Niu J, Wang Z, Xu W, Qiao Z, Gu Y. Astragalus embranaceus extract activates immune response in macrophages via heparanase. Molecules. 2012 Jun 13;17(6):7232-40. doi: 10.3390/molecules17067232. PMID: 22695229; PMCID: PMC6268577.

ix. Dion, C., Chappuis, E., & Ripoll, C. (2016). Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials. Nutrition & metabolism, 13, 28. https://doi.org/10.1186/s12986-016-0086-x

x. Zhai, Z., Liu, Y., Wu, L., Senchina, D. S., Wurtele, E. S., Murphy, P. A., Kohut, M. L., & Cunnick, J. E. (2007). Enhancement of innate and adaptive immune functions by multiple Echinacea species. Journal of medicinal food, 10(3), 423434. https://doi.org/10.1089/jmf.2006.257

Go here to read the rest:
Why are essential vitamins and botanicals continue to be overlooked? - Modern Ghana

The pandemic has provided fertile conditions for conspiracy theories and conspirituality in Australia – ABC News

Posted: at 5:59 pm

The perpetuation of and interest in conspiracies has proliferated during the COVID-19 pandemic. Conspiracy theories often blend historical, religious, and scientific ideas by way of challenging official explanations of events and data provided by authorities, academics, and mainstream media. They then create alternate narratives based on distortions and widely circulate them predominantly, these days, through social media.

Charlotte Ward and David Voas first coined the term conspirituality in 2011, to describe the merger of conspiracy theories and New Age spirituality. They argued that these conspiritualist movements are united by a politico-spiritual philosophy, which posits that a group of elites has covert control of society and then calls for a paradigm shift in consciousness that harnesses cosmic forces to emancipate society from the grip of those elites.

It seems to us that Ward and Voass insights remain highly applicable to the current viral outbreak of what we call (con)spirituality, which has arisen in response to the COVID-19 pandemic and is focussed on a critique of modern technology, medicine, and governance. We chose to bracket the con because many spiritual people and groups questioning of modernity is critical, informed, and non-violent, particularly where they are working toward more holistic and sustainable ways of living and healing, and employing ideas and practices whose validity is bolstered by science. Concurrently, there are rising numbers of people with conspiritual views who are claiming that the COVID-19 pandemic is a construct of the deep-state and a sign of end-times, often aligned with ideas emanating from the far-right, apocalyptic QAnon movement which frequently draws on Christian millenarianism.

Adherents to QAnon argue that COVID-19 isnt real, and instead was created by deep-state government officials and elites. The movement focuses on a Great Awakening, whereby people will be able to discover this hidden truth. As Adrienne LaFrance highlights, QAnon is a movement united in mass rejection of reason, objectivity, and other Enlightenment values and propelled by paranoia populism [and] religious faith. Facebook hosts thousands of QAnon groups with millions of members, and QAnon itself has been identified as a domestic terror threat by the FBI.

Want the best of Religion & Ethics delivered to your mailbox? Sign up for our weekly newsletter.

What QAnon and conspiritualists share with many other religious extremist movements are their exclusive religious and spiritual narratives which depict adherents as privy to the real truth and thus more enlightened than mainstream society. They tend to see themselves as persecuted and believe that they will ultimately be vindicated. Contemporary spirituality is individualised, based on personal choice, and commodified, which is why conspiritualists are particularly irate about coronavirus restrictions that threaten their personal freedom. At the same time, these individuals have formed conspiritual social movements what Nancy Ammerman calls spiritual tribes which are deeply social with distinct and exclusive beliefs, language, and codes, calling for societal transformation.

An under-explored aspect of conspirituality is the white privilege that persists within these movements and their connection with spiritual frameworks of abundance. The coronavirus lockdowns have not only inhibited personal freedoms but have also had significant economic costs to peoples livelihoods and lifestyles. Contemporary spirituality places an emphasis on positive thinking for personal wellbeing and economic gains, and yet individuals cannot simply think themselves out of this COVID-19 crisis. This has resulted in mass spiritual bypassing, with more privileged individuals and groups who are far less likely to be affected by the coronavirus denying the reality of the suffering that the virus is inflicting on the less privileged and more vulnerable.

In the latest census, 30 per cent of Australians stated they had No Religion. A nationally representative 2018 Australian Survey of Social Attitudes found that 24 per cent of adults agreed with the statement, I dont follow a religion, but consider myself to be a spiritual person; and 17 per cent said they were religious and spiritual. A nationally representative survey of 1,200 young people aged between 13 and 18 also revealed 22 per cent were Spiritual but not Religious, while 16 per cent were Religious and Spiritual. There has been a significant uptake of spiritual practices online across Australia to help cope with the COVID-19 pandemic, and research also shows that Australians turn to alternative therapies because they are disillusioned with Western medicine and have lost faith in modernity, science, and technology to solve pressing global issues. (It goes without saying that not all who self-identify as spiritual or partake in holistic medicine necessarily buy into conspiracy theories.)

Conspiracy videos and documentaries such as those of the infamous conspiritualist David Icke, Plandemic, and Americas Frontline Doctors have attracted a substantial Australian audience. Australian celebrities and influencers have embraced (con)spiritual ideas most notably celebrity chef Pete Evans, and former reality show participant Fanos Panayides. Other figures within the Australian wellness movement have also gained notoriety by posting videos and/or participating on Panayidess and Raphael Fernandezs 99%Unite platform. These self-proclaimed experts mobilise social media and then profit from the attention they garner. At the same time, other Australians who are prominent in the wellness industry like Sarah Wilson have publicly critiqued conspiritual views.

Protests directed against 5G, Bill Gates, vaccines, and masks, and demonstrations for the reclaiming of freedom and sovereignty have been organised in Australian cities and attended by QAnon supporters and others with conspiritual views. Protests have been more frequent in Melbourne than elsewhere in Australia due to its stricter and longer lockdown measures. Australia was also found to be one of the top-four countries contributing to QAnon discussions on Twitter. In an Essential Report poll of 1,000 Australian adults, 13 per cent (which rose to 20 per cent among 18-34 year-olds) thought that COVID-19 was not dangerous and was being used to force people to be vaccinated, and that Bill Gates has played a role in creating and spreading COVID-19. These are substantial and disturbing minorities. And not only are there growing numbers of people attracted to these movements, the movements themselves are becoming more radical and vocal through social media.

As with many social movements, those with extreme and dangerous conspiritual views are a very small minority within broader spiritual movements. Nevertheless, it is critical that we better understand their internal diversity and complexity, as well as the processes of radicalisation occurring within them and their links with QAnon.

Associate Professor Anna Halafoff is a sociologist of religion, and a member of the Alfred Deakin Institute for Citizenship and Globalisation, the Centre for Resilient and Inclusive Societies Consortium, and the AVERT (Addressing Violent Extremism and Radicalisation to Terrorism) Research Network at Deakin University. She is the author of The Multifaith Movement: Global Risks and Cosmopolitan Solutions, and co-author (with Andrew Singleton, Mary Lou Rasmussen, and Gary Bouma) of Freedoms, Faiths and Futures: Teenage Australians on Religion, Sexuality and Diversity.

Dr Enqi Wengis a Research Fellow at the Alfred Deakin Institute for Citizenship and Globalisation, Deakin University, and the author of Media Perceptions of Religious Changes in Australia: Of Dominance and Diversity.

Professor Andrew Singleton is a sociologist in the School of Social Sciences and Humanities at Deakin University. He is author of Religion, Culture and Society: A Global Approach, co-author (with Anna Halafoff, Mary Lou Rasmussen, and Gary Bouma) of Freedoms, Faiths and Futures: Teenage Australians on Religion, Sexuality and Diversity, and co-author (with Michael Mason and Ruth Webber) of The Spirit of Generation Y: Young Peoples Spirituality in a Changing Australia.

Cristina Rocha is Professor of Anthropology and the Director of the Religion and Society Research Cluster at the Western Sydney University. She is a former president (2018-2019) of the Australian Association for the Study of Religion, and she co-edits the Journal of Global Buddhism and the Religion in the Americas series. She is the author of John of God: The Globalisation of Brazilian Faith Healing and Zen in Brazil: The Quest for Cosmopolitan Modernity.

Dr Alexandra Roginski is a Research Fellow at the Alfred Deakin Institute for Citizenship and Globalisation, Deakin University. She is the author of The Hanged Man and the Body Thief: Finding Lives in a Museum Mystery.

Emily Marriott is a PhD student in Sociology at Deakin University. She has recently worked as a Research Assistant on an Australian Research Council Discovery Project on Religious Diversity in Australia: Strategies to Maintain Social Cohesion.

More here:
The pandemic has provided fertile conditions for conspiracy theories and conspirituality in Australia - ABC News

Americans Are Still Paying Out of Pocket for Complementary and Alternative Medicine – Shepherd Express

Posted: at 5:59 pm

Garlicky chicken soup was once the standard cure for a cold and peppermint was used to soothe an upset stomach rather than going to the drugstore for an over-the-counter pill. Grandmas remedies have been coming back in a big way: About 59 million Americans spend money out of pocket on complementary health approaches, totaling approximately $30.2 billion a year, according to information provided by the National Center for Complementary and Integrative Health (NCCIH)a U.S. government agency housed under the National Institutes of Health that explores integrative and alternative medicine.

Complementary (also called integrative) medicine is when a non-mainstream practice is used in conjunction with conventional medicine. Alternative medicine uses non-mainstream practices in place of conventional medicine. Theyre often referred to together as Complementary and Alternative Medicine (CAM) and have a similar objective: to find and treat the underlying causes of health problems rather than to just address symptoms.

CAM practitioners use holistic and preventive approaches to relieve and cure ailments ranging from the common cold to inflammatory conditions like arthritis. CAM treatments include herbs, whole foods nutrition and preventive lifestyle habits to support health, such as exercise, avoiding processed foods and smoking, stress management and light or no alcohol use. CAM also includes chiropractic, yoga, meditation, vitamins, minerals and natural anti-inflammatories and antioxidants, as well as ancient healing approaches such as acupuncture.

Carol Brown is a Doctor of Osteopathic Medicine. She had worked in conventional medicine as a primary care physician before training in integrative methods. Sixteen years ago, she formed her own integrative practice in Oak Creek, Wis., CMB Health Specialties (formerly known as the Center for Integrative Health Care). Brown uses holistic approaches such as nutritional support, specialty lab testing to detect food allergies-sensitivities and hormonal imbalances, as well as intravenous nutrition therapy. She uses conventional medicine as appropriate and may refer patients to practitioners of alternative services, such as acupuncture or massage, or to conventional medicine physicians.

Stay on top of the news of the daySubscribe to our free, daily e-newsletter to get Milwaukee's latest local news, restaurants, music, arts and entertainment and events delivered right to your inbox every weekday, plus a bonus Week in Review email on Saturdays.

Integrative medicine gets back to physiology; how does the body work, and what do we need to do to make it work? Brown says. Its about nutrition, supplying what the body needs and looking for underlying causes. If someone has a headache, there are pills for headaches, but we look to find out why they have a headache. It could be gluten intolerance, not enough sleep or any number of underlying issues.

Brown notes there is a population of people that are not helped by everyday medicine and are driven to seek care outside of conventional approaches. Theyre looking for some other way to help themselves. Theres also a population of older patients who know how medicine used to be, where there was more time to get to the bottom of ones health. Younger people are suspicious, because everyday medicine has become so commercialized. A lot of people are afraid to take a drug, and they want to get better without meds if that is possible, she says.

Sarah Axtell is a naturopathic doctor and founder of Lakeside Natural Medicine in Shorewood, Wis. A licensed naturopathic doctor is a primary care physician who is trained to diagnose and prescribe, as opposed to traditional naturopath who can do neither.

She also sees a growing demand for CAM approaches. With a shortage of primary care doctors, exponentially escalating health care costs, epidemics of lifestyle-related chronic disease and obesity and increasing dissatisfaction with conventional medicine, naturopathic doctors are a valuable solution in light of these critical shortages, she says.

Naturopathic approaches emphasize direct care, prevention, wellness and health promotion. Axtell has a doctorate in naturopathic medicine from the National University of Natural Medicine and is board certified by the North American Board of Naturopathic Examiners. Shes currently licensed as a primary care physician in the state of Oregonone of 22 states that has licensing or registration laws for naturopathic doctors.

Axtell notes that a licensed naturopathic doctor attends a four-year, in-residence, graduate-level naturopathic medical school; studies conventional, holistic and nontoxic approaches to therapy; is educated in the identical basic sciences as an M.D. or D.O. (Doctor of Medicine or Doctor of Osteopathic Medicine); has three years supervised clinical training as part of medical school; and takes rigorous, national, professional board exams. Shes one of many licensed naturopathic doctors in the state advocating for naturopathic licensure in Wisconsin.

We are gaining momentum here in Wisconsin and hope to gain licensure in the near future, Axtell says. The Wisconsin Naturopathic Doctors Association has generated great support from both Democrats and Republicans in both houses of the legislature. They have worked hard to educate legislators on the importance of licensure for NDs. When legislators fully grasp the positive impact naturopathic medicine has on the health of Wisconsinites, legislators in turn support licensure, which will increase access to and ensure safe delivery care by highly trained natural medical providers. The Association hopes to see a licensure bill introduced in the 2021 session.

The Wisconsin Department of Safety and Professional Services is the state agency that licenses medical professionals, including M.D.s, D.O.s, nurse practitioners and dieticians. They also license professionals practicing alternative medicine modalities such as chiropractic, acupuncture and massage. Theres currently no state licensing required to practice alternative therapies like aromatherapy, biofeedback, herbalism or nutrition counseling-coaching. Training in those methods often range from self-study to certification through trade organizations or associations that offer online distance learning to in-person classes and workshops that issue certification.


Its easy to get lost on the internet when researching the efficacy of CAM therapies, and like any topic, there are articles that both support and criticize it. The NCCIH was established with a focus to conduct and support research and provide information about complementary health products and practices. Brown likes to refer people to PubMed, a comprehensive database of scientific and medical journals documenting peer-reviewed studies, many of which have researched CAM topics.

Theres actually a ton of research out there, Brown says, and she points to the Cleveland Clinics Integrative and Lifestyle Medicine Department as an example of a big hospital system that has implemented CAM approaches. She notes that countries such as Germany, Sweden, Italy and Japan have done advanced research on CAM therapies, but here in the U.S., drug companies have the deep pockets to fund a myriad of large-scale studies that dwarf non-profitable natural approaches. But some of the strongest proof that CAM therapies work has come from its users. The evidence of getting better is proof enough, Brown affirms.

Most major health insurance plans dont cover CAM therapies and are quick to deem them as experimental or not medically necessary. Some cover CAM therapies such as chiropractic care with restrictions or co-pays or include CAM in flex spending accounts (people are advised to first check with their insurance companies to find out what services are covered). Most practices offering integrative or naturopathic careor services considered alternative, like acupuncture, massage or nutrition counselingdo not accept insurance and are private pay, which can be a prohibitive cost for some people.

But some alternative medicine providers are striving to make their services more affordable. Milwaukee Community Acupuncture is a 501(c)(3) nonprofit offering acupuncture on a pay-what-you-can model, with a sliding scale from $20 to $50 per visit. Amy Severinsen is a licensed acupuncturist who co-founded Milwaukee Community Acupuncture with Oliva Crane. Severinsen realized the need for affordable acupuncture after she visited China and toured acupuncture clinics and saw how affordable it was for people there, so people came in more frequently.

Previously, I had a private practice, and people responded really well, but because they were paying out of pocket, they couldnt afford to keep coming in, she says. Acupuncture works best when a patient receives a series of treatments. Because one doesnt have to disrobe while receiving an acupuncture treatment, Milwaukee Community Acupunctures professionals can see more than one person per hour in a group setting, making their community model cost-effective. The COVID-19 pandemic has forced them to alter their business to see fewer patients in the treatment room at one time; check the website for COVID-19 safety precuations.

Severinsen believes most insurance companies dont cover alternative therapies such as acupuncture because stronger studies are needed to support its effectiveness. Once they see those results, I think they will offer to cover more, she says. I also think its difficult to plug acupuncture into the system of coding and diagnosis, because its a different way of diagnosing people and looking at the body.

Sheila Julson is a freelance writer who enjoys capturing the stories behind Milwaukees happening food, beverage and urban farming scenes. She also pens articles about holistic health, green living, sustainability and human-interest features.

See more here:
Americans Are Still Paying Out of Pocket for Complementary and Alternative Medicine - Shepherd Express

#BlackInCancer Week Highlights The Contributions Of Black People In Cancer Medicine And Research – Forbes

Posted: at 5:59 pm

The BlackInCancer event aims to highlight the contributions of Black researchers, physicians and ... [+] patient advocates to cancer medicine and research.

An event taking place this week on social media platforms Twitter and Instagram is highlighting the contributions of Black researchers, physicians and patient advocates working in cancer research and medicine.

Black In Cancer week was founded by two cancer research scientists; Dr Henry J. Henderson III, a postdoctoral researcher at Vanderbilt University in Nashville, Tennessee and Sigourney Bell, a PhD student at the Cancer Research U.K. Institute at the University of Cambridge in the U.K.

We wanted to amplify Black voices and contributions to cancer research in medicine, said Henderson. We wanted to make our presence known because oftentimes we are seen as rare in this space.We are a strong believer of they cant be what they dont see, so this is our way of championing change in the cancer field, he added.

Dr Henry J. Henderson III, PhD, a postdoctoral research scientist at Vanderbilt University focuses ... [+] on optimizing treatments for people with non-small cell lung cancer.

Implicit bias is a major issue. It is rooted in (but not limited to) not being used to seeing Black people as principal investigators, clinicians, etc.This affects everything from research funding to opportunities to progress in our careers, said Henderson.

Together, Bell and Henderson head up an extensive organizing committee of researchers and physicians who have scheduled several online events during the week. With sponsors including Fred Hutchinson Cancer Research Center in Seattle, Tigerlily Foundation and Cancer Research U.K., the events cover several topics from career advice and networking to cancer advocacy and survival disparities.

Figures from the American Society for Clinical Oncology in 2016 showed that although 13% of the U.S. population is Black, only 2.3% of practicing oncologists self identified as Black or African American. For researchers, this is harder to quantify, but it is generally accepted that Black scientists are also grossly under-represented in the cancer research field.

I have been questioned harshly about my research and the authenticity of my authorship, said Henderson. I cannot say that it was because the color of my skin but ironically, several people next to me (who were not Black and are highly represented in the field) did not receive the same treatment, he added.

So what does the BlackInCancer event hope to achieve?

We wanted to create an all inclusive community, said Bell. Research within the lab is not the only way we can work towards more people surviving cancer. Within the Black community, we need more cancer education as well as to build those support networks for those with cancer. Our aim was to create a holistic environment to network, support and educate all Black people that either work in or are affected by cancer, Bell added.

Sigourney Bell, one of the co-founders of BlackInCancer week, is a PhD candidate at the University ... [+] of Cambridge in the U.K. Her research focuses on developing models and therapeutics for a rare childhood brain tumor.

Black people with cancer often experience huge disparities in survival, provision of care and access to clinical trials for experimental treatments. Just last month, the American Association for Cancer Research published a report detailing these disparities, noting that overall, Black Americans have a 14% higher cancer death rate than White Americans.

What impact do the organizers hope that the event will have going forward?

We hope that people will feel more knowledgeable about cancer and more empowered about their health decisions. We hope that researchers are able to find and build their network and that young Black STEM students are able to see what they are able to aspire to, said Bell, adding that for the future, the organizers are planning cancer education initiatives and also mentorship programs for students both in the U.S. and the U.K.

Original post:
#BlackInCancer Week Highlights The Contributions Of Black People In Cancer Medicine And Research - Forbes

University Hospitals Cleveland Medical Center Joins the Cardiometabolic Center Alliance as a Key Strategic Partner and Charter Member – Newswise

Posted: at 5:59 pm

Newswise Kansas City, Missouri & Cleveland, Ohio--The Cardiometabolic Center Alliance (CMCA), founded by Saint Lukes Mid America Heart Institute is pleased to announce the addition of University Hospitals Cleveland Medical Center as Key Strategic Partner and Charter Member.

As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D) and related cardiovascular (CV) and renal comorbidities, the CMCA considers University Hospitals (UH) a large integrated health system based in Cleveland, Ohio a key member of the Alliance.

The goal of the Cardiometabolic Center Alliance is building on our existing success in Kansas City by working collaboratively with our member organizations to replicate and refine our novel clinical care delivery model, with the overarching objective of lessening the adverse impact of diabetes and its most common and morbid complications cardiovascular and kidney disease - on patients lives, said Dr. Mikhail Kosiborod, Cardiometabolic Center Alliance Executive Director. The addition of UH as a Strategic Partner and Charter Member of the CMCA is an essential step in meeting our mission of improving the quality of care and outcomes of patients with cardiometabolic disease, so they can live longer, healthier, and more active lives, no matter where they live.

Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 50 health centers and outpatient facilities, and 200 physician offices in 16 counties throughout northern Ohio.The systems flagship academic medical center, University Hospitals Cleveland Medical Center, located in Clevelands University Circle, is affiliated with Case Western Reserve University School of Medicine.

We are excited to be a part of this national alliance that will pave the way for new treatments and approaches to manage patients with cardiometabolic disorders, said Sanjay Rajagopalan, MD, Chief of Cardiovascular Medicine at UH Harrington Heart & Vascular Institute. Cardiologists are uniquely positioned to assist with the seismic shift occurring in the landscape of care for diabetes and cardiovascular complications. However, these diseases require a large degree of collaboration with other specialties. In order to provide the highest quality of care for patients, its important that we take a multidisciplinary team approach and intervene early.

Through personalized medicine and research collaborations, such as UH and CMCA, enhancements can be made for detecting disease early, developing therapeutics for treatment, and refining technology-based approaches to improve patients lives.

At UH, we are focused on providing the best value for our patients, said Peter Pronovost, MD, PhD, Chief Clinical Transformation Officer at UH. This unique alliance will help us track treatment patterns and quality of care, and will help us transform care delivery for patients at risk for future complications.


Alliance members will adopt and implement a novel care model designed and successfully implemented bySaint Lukes Michael & Marlys Haverty Cardiometabolic Center of Excellencein Kansas City, MO. Based on the initial data, under this model the rates of optimal guideline-directed medical therapy substantially increased over the national average, ensuring that patients with T2D receive care that is aimed at both optimizing diabetes management and providing comprehensive cardiovascular risk reduction with therapies proven to improve outcomes. These results are made possible by a unified team of clinicians from across the disease continuum, who focus on holistic, guideline-directed preventative care. Through their participation, Alliance members will also contribute to a national registry that will track treatment patterns and quality of care. As the Alliance enhances its capabilities, improves processes, and expands research opportunities on a national scale, the ultimate goal is improved patient outcomes.

About University Hospitals / Cleveland, OhioUniversity Hospitals also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top childrens hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; University Hospitals Harrington Heart & Vascular Institute, a high-volume national referral center for complex cardiovascular procedures; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including Americas Best Hospitals from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals part of The Harrington Project for Discovery & Development. UH isone of the largest employers in Northeast Ohio with 28,000 physicians and employees. Advancing the Science of Health and the Art of Compassion is UHs vision for benefitting its patients into the future, and the organizations unwavering mission is To Heal. To Teach. To Discover.Follow UH on LinkedIn, Facebook @UniversityHospitalsand Twitter @UHhospitals. For more information, visitUHhospitals.org.

See the original post:
University Hospitals Cleveland Medical Center Joins the Cardiometabolic Center Alliance as a Key Strategic Partner and Charter Member - Newswise

Dr. Purshotam Lal – Transforming healthcare with a vision Envisioning a healthy India, Metro Group of Hospitals – Outlook India

Posted: at 5:59 pm

(Eds: Disclaimer: The following press release comes to you under an arrangement with Mediawire. PTI takes no editorial responsibility for the same.) Adversities could never stop great personalities from fulfilling their dreams. A seemingly ordinary boy hailing from a remote village in Punjab never let adversities come in his way of achieving his dreams. He studied under the street lights never complaining about the lack of resources and today he heads the renowned Metro Group of Hospitals. Dr. Purshotam Lal is a visionary who with his sheer will power and ardent desire to serve the masses has achieved the unimaginable feats in the field of heart care. He is internationally acclaimed for his monumental feats in the medical field and has been duly recognized and honoured with prestigious awards including Padma Vibhushan, Padma Bhushan and Dr. B.C. Roy National Award and many others. Dr. Lal is a fellow of American College of Cardiology, American College of Medicine, Royal College of Physician (Canada), British Cardiovascular Interventional Society, German Society of Cardiovascular Research, Fellow of Society of Cardiac Angiography and Interventions, USA, etc. He has also trained at many other leading institutions across the world. Motivated by the desire to serve the people of his country, he left a flourishing medical career in the USA and he moved back to India to serve his country. He pioneered several innovative procedures in the field of Interventional Cardiology for the first time in the country such as Slow Rotational Angioplasty, Atherectomy, Rotablator, Stenting, Heart hole closure, etc. to provide contemporary world-class healthcare at an affordable cost. Armed with the vision to provide excellent healthcare at an affordable cost he pioneered several low budget medical technologies with the intent to serve masses. He conceptualized and developed techniques of Aortofemoral bypass support (partial artificial heart), Opening of tight heart valves with echo without Cath Lab. He is attributed with performing the first case of Non-surgical heart hole closure (ASD) with monodisc device and the first case of Non-surgical aortic valve replacement with core valve, both being the first time in the world. He is the first investigator of Inoue Balloon Mitral Valvuloplasty in the Country and his name has been listed in the Limca Book of World Records. A crusader against unethical commercialization of medical services, Dr. Lal has established twelve state-of-the-art Hospitals to provide world-class medical care at an affordable cost. In pursuance of his mission, he has committed himself to serve the poor and needy and performs advanced cardio-vascular procedures at the most affordable cost. His ideology which states that No patient is ever turned back for want of money has been implemented ardently across all Metro Hospitals. He has been recognized by the Express Healthcare as Creator of Affordable Healthcare for selflessly serving an ever-increasing number of poor patients either free or at concessional rates. Founded with the vision to provide advanced healthcare at affordable prices, Metro Group of Hospitals has made advanced healthcare facilities accessible to the masses of India. Over the past 2 decades, Metro Group has emerged as a leading advanced medical care provider with an exceptional team of healthcare professionals dedicated to providing excellent medical services with empathetic care. Metro Group of Hospitals is a group of 12 Multi Specialty hospitals across India, out of which 10 are NABH Accredited and 4 are NABL Accredited. Metro Group of Hospitals has an exceptional team of specialists led by Dr. Purshotam Lal. committed to providing incredible healthcare. Metro hospitals provide multispecialty care for 35 Chief and Allied-specialities that include Anaesthesiology, Cardiology & CTVS, Dentistry, Gastroenterology & Gastro Surgery, Internal Medicine, Neurosciences, Obstetrics and Gynaecology, Oncology & Oncosurgery, Orthopaedics, Joint Replacement & Spine Surgery, Paediatrics & Neonatology, Physiotherapy Plastic, Cosmetic & Reconstructive Surgery, Pulmonology & Sleep Medicine, Rheumatology, Stem Cell Therapy, Bariatric & Metabolic Surgery, Blood Bank, Dermatology, Endocrinology And Diabetes, ENT & Cochlear Implant, Haematology, Holistic Medicine, Homeopathy, Interventional Radiology Laboratory, Laparoscopic & General Surgery, Nephrology & Renal Transplant, Nutrition & Health, Ophthalmology, Metro Eye Centre, Psychiatry, Psychology, Radiology, and Urology. Metro Group of Hospital is trusted by medical professionals across the country for providing tertiary care to critical patents requiring complex healthcare procedures. Metro Group encourages and invests in research and development under the leadership of Dr. Lal. to make advanced healthcare accessible to masses. Now, patients from beyond the borders seek medical care at Metro Group where they are provided with advanced healthcare under the care of empathetic medical professionals. Metro Group of Hospitals aims to touch a million lives with care and expand their facilities to make advanced healthcare accessible to people all over the country and world. Metro Group of Hospitals is committed to providing advanced healthcare at an affordable cost. Website: http://www.metrohospitals.com PWRPWR Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI More from Outlook Magazine

See more here:
Dr. Purshotam Lal - Transforming healthcare with a vision Envisioning a healthy India, Metro Group of Hospitals - Outlook India

The social and economic benefits of a holistic health system – InDaily

Posted: at 5:59 pm

Hammering out a new manufacturing policy What we know today, Friday October 16 ICAC clears ex-ministers among nine country MPs Minister tells developer: hands off threatened art deco building Norwood

The COVID-19 crisis has brought pressure on the nations healthcare system and a focus on the way it operates. Today, on Allied Health Professions Day, the vital role of all health professions and the need for integrated, long-term healthcare outcomes should be recognised by policymakers, argues Esther May.

COVID-19 is the biggest crisis to face our healthcare system this century.

Yet the pandemic also presents an opportunity for reinvention and innovation with a more integrated and holistic approach to health provision in the community, ensuring higher levels of wellbeing in the future, and generating positive economic outcomes.

The release of the 2020/21 Federal Budget last week did not offer any major changes to the current healthcare system. While there were certainly positive moves by the government to address some immediate issues, including extending funding for telehealth services and more assistance for rural health, there are missed opportunities in recognising the role of allied health services in Australias post-coronavirus recovery.

For too long the contribution by the diverse range of health professionals working in this space has been downplayed and sidelined by the existing structure of the current health system.

Allied health represents 25 per cent of the healthcare workforce. Many of these professionals are unsung heroes working at the coalface in the community, both in cities and in more remote regions to speed recovery from illness, and to help people of all ages to live comfortable, independent, and fulfilling lives. In many instances they are also ensuring better workforce participation which aids the economy.

The problem lies in the fact that the three pillars of healthcare (medicine, nursing and allied health) are currently not designed to work as an integrated multidiscipline team, especially out of the hospital setting. In addition, access to Medicare-rebated services for allied health services can be a complicated process. Out-of-pocket expenses remain a barrier to patients accessing the therapies they need for long-term recovery, or quality of life. This needs to change if we are to have any hope of improving outcomes.

While the role doctors and nurses have in the diagnosis and treatment of patients is clear, the contribution of other primary care providers including clinical psychologists, social workers, occupational therapists, dieticians, and various rehabilitation professionals is still not widely understood or acknowledged, despite significant research demonstrating how various allied health interventions result in measurable health outcomes.

If policies could encourage healthcare professions to come together rather than working separately, it would ultimately reduce the economic burden on the healthcare system which is now under extraordinary pressure.

In 2015 a Deloitte Access Economics study (Value of Accredited Exercise Physiologists in Australia) demonstrated that Accredited Exercise Physiologist (AEP) interventions provided significant return on investment when treating people with chronic conditions, including diabetes, mental illness and cardiovascular disease.

In the case of cardiovascular disease, one of the most significant health issues in Australia, the total lifetime burden of disease savings resulting from intervention with an AEP was estimated to be $11,847 per person annually, compared to a delivery cost of $1,903. Similar results were found in research papers examining post-stroke recovery, especially in rural and regional areas where allied health workers are often in short supply.

Ironically, COVID-19 may be just what is needed to jolt the system into a reboot, with allied health professions now gaining more recognition around the world as policy makers begin to understand more about the economic and social benefits of a wider, person-centred approach to wellness and recovery from disease. We have only to look to the UK and Canada for inspiration where allied health workers have been at the forefront assisting medical teams with coronavirus recovery both in acute settings and in the community.

In Australia the 2020 aged care royal commission report has recommended more support from allied health services in aged care facilities and in-home settings. Likewise, with the tsunami of mental health issues now facing people across Australia, healthcare experts from all sides are lobbying for better funding of psychological support services.

Ongoing research is also important. Universities have been working hard at this time, not just to make sure allied health graduates are appropriately skilled to cope with the post-COVID-19 environment, but also in terms of understanding how new delivery modes like tele-health, Zoom sessions, and use of new technology (like virtual reality or music therapy apps, for example) can make a difference to delivering better health outcomes.

While the Federal Budget has included $1 billion in additional funding for research at universities around the country, much work will be needed in the development of evidence-based preventative health programs to aid rehabilitation for a range of health problems. Already work is progressing on innovative exercise therapies to address anxiety and depression, and programs to address the rising incidents of dementia and social isolation in the elderly.

Supply of future allied health workers may also be an issue. Disruptions during the lockdown have caused delays to clinical placements for final-year students. Universities may not be able to produce graduates fast enough to meet the demand in key areas like mental health, disability care, education and social support, and aged care.

Increasing the number of partnerships between healthcare providers in the public, private, and tertiary training institutions will be required so we can build better workforce capacity into the future.

Get InDaily in your inbox. Daily. The best local news every workday at lunch time.

Thanks for signing up to the InDaily newsletter.

COVID-19 is the biggest health, social and economic catastrophe we have faced in our lifetime. But if there is one thing that this pandemic has taught us, it is the need to be flexible and open to doing things differently.

An estimated 80 per cent of the burden of disease and injury suffered by Australians is now attributable to chronic conditions, COVID-19 is likely to make that worse. Greater access to early intervention, prevention, and treatment programs managed by allied health professionals will help to improve outcomes and save money.

Allied health can no longer be viewed as an optional extra: rather it is an investment for our future.

Professor Esther May is Dean of Health Sciences at UniSA and chair of the Australian Council of Deans of Health Sciences

In times like these InDaily provides valuable, local independent journalism in South Australia. As a news organisation it offers an alternative to The Advertiser, a different voice and a closer look at what is happening in our city and state for free. Any contribution to help fund our work is appreciated. Please click below to donate to InDaily.

Powered by PressPatron

Continued here:
The social and economic benefits of a holistic health system - InDaily

Sage-Gavin: Caring is the right thing to doand good for business – Human Resource Executive

Posted: at 5:59 pm

HR Leadership columnist Eva Sage-Gavin is a distinguished HR thought leader and former CHRO with more than three decades of broad experience in Fortune 500 global consumer, technology and retail corporations. She currently serves as the senior managing director for Accentures global talent & organization consulting practice and as a technology Board Director. She can be emailed at hreletters@lrp.com.

The unprecedented and extraordinary challenges in 2020 have created opportunities for leaders to show up for their people in innovative and progressive ways. Trailblazing leaders take more responsibility for workers holistic wellbeing and seek to provide clarity and earn their trust.

And workers now expect more from employers, as in many parts of the world, homes have transformed into workplaces, schools and childcare centers. People are seeking a path forward to help meet their needs and those of their families through a continued period of volatility and unpredictability. Of the many expectations being expressed, compassionate leadership is a priority.

Just Capital ranks companies on the issues people care about most. It found that 92% of people believe companies should promote an economy that serves all. And 50% of those surveyed believe enterprises are currently achieving this aim.

Accentures new research, Care To Do Better, found that by meeting six fundamental human needs through work, companies unlock their peoples full potential and drive growth. The report found 78% of workers feel their employers should be responsible for their whole-person care. Importantly, around half of CXOs interviewed for the research thought the sameup from 35% before the pandemic. The report shows that companies that focus on making their people net better off unlock their full potential and grow faster as a result.

Change is Changing for the Better

Businesses are putting in place social innovations to improve their workers lives to an extent Ive not seen in my 30-plus-year career. C-level executives and board members I talk with say they are taking a close look at how their people feel, physically and mentally, and asking what they can do to help improve their employees whole-person care. They are looking at ways to improve social justice, diversity, equity and inclusion for their people, businesses, boards and communities to survive, thrive and grow. We see evolving examples of these changes and early shifts at a company, community and societal level.

Earlier this summer, tech giant Cisco Systems pledged $100 million to further social justice causes. Last month, it announced a series of pledges and action items to promote equal rights, diversity and pay parityboth within the companys employee base and beyond. Starting in 2021, Cisco will require preferred suppliers to report workforce diversity statistics to Cisco annually.

I recently talked to Francine (Fran) Katsoudas, Ciscos chief people officer, about Ciscos Social Justice Beliefs and Actions initiative. She said this approach helps Ciscos people feel they belong and ensures they can see themselves in the companys future. Its an inspiring approach, and Cisco has seen an uptick in their peoples creativity and productivity.

The HR community has long talked about how we should have a seat on boards and partner closely across the C-suite to drive change. Fran, and her team, turned this on its head and instead asked what the business can learn from workers. This is truly inspiring.

Cisco has genuinely cultivated a conscious culture, where workers have as much responsibility for culture and innovation as leadership. Workers are empowered to bring ideas to executivesmany of which go on to be adopted. Their people are also given full transparency when issues arise within the company. This partnership level between workers and employers builds trust and reinforces the message that leadership is for everyone.

Empathy in Action

Ellyn Shook (Photo by Dorothy Shi Studio)

Some of the best examples of employee empowerment come from CHROs using one of the most powerful tools at their disposal: Empathy. No one knows the power of empathy better than Ellyn Shook, Accentures chief leadership and human resources officer. Ellyn has just been namedHREs HR Executive of the Yearin recognition of her compassionate work and her leadership in responding to the many new priorities brought by the COVID-19 pandemic with unique, breakthrough, collaborative solutions.

For Ellyn, taking care of the mental and physical wellbeing of individuals is paramount. During the pandemic, this has meant listening to people and giving them the means to look after their own wellbeing. For example, Ellyn has launched an e-learning course, Thriving Mind. Developed in partnership with Thrive Global, and research from Stanford Medicine, the course focuses on holistic wellbeing and helps workers think through their feelings. While set in motion before the pandemic, the program has proved invaluable in helping people build resilience during this difficult time.

See more from Eva Sage-Gavin HERE.

By empathizing with people and giving them empowering support, Ellyns course has had unprecedented engagement, with 130,000 participants in less than two months and is a visible action in support of the wellbeing of Accentures workers.

Positive work experiences that unleash peoples full potential, where they all feel valued, supported and empowered, helps businesses emerge better than before from these challenging times. Simply put, it pays to care, and we all need it now more than ever.

Read this article:
Sage-Gavin: Caring is the right thing to doand good for business - Human Resource Executive

Maryland University of Integrative Health announces educational partnership with the American Public Health Association Wall Street Call – Reported…

Posted: at 5:59 pm

Oct 14, 2020 10:00 AM ET

iCrowd Newswire Oct 14, 2020

Laurel, Md. Maryland University of Integrative Health (MUIH) is pleased to announce a new partnership with the American Public Health Association (APHA). MUIH and APHA have entered an educational collaboration with the shared goal of promoting the use of holistic and natural approaches to promote well-being. This collaboration expands MUIHs role in supporting the health and wellness of public health professionals throughout the U.S.

MUIHs health promotion program faculty and students are collaborating with APHAs Integrative, Complementary and Traditional Health Practice (ICTHP) group to develop and deliver well-inars for APHA members. These well-inars are designed to promote the wellbeing of APHA members through mindfulness exercises designed to promote relaxation and relieve stress. They also provide MUIH health promotion students with the opportunity to apply the program development, delivery, and assessment skills and knowledge learned in their program.

Claudia Joy Wingo, chair of MUIHs health promotion program and a member of the ICTHP group says Were pleased to be able to share our expertise in the field of complementary and integrative medicine with members of APHA as it is the foundation of MUIHs educational purpose. By providing a virtual walk in nature using guided imagery, we endeavor to provide members with a relaxing respite for the stresses of daily life.

Health promotion faculty member Katherine Smith says We are combining two evidence-based integrative approaches, guided imagery and nature therapy, that can have significant positive health effects. Its an exciting opportunity to be able to offer these relaxation practices to APHAs 30,000 members during a stressful global pandemic.

MUIH has offered an online Master of Science in Health Promotion with a focus on integrative health practices since 2014, and in 2018 added a Post-Baccalaureate Certificate in Workplace Wellness. MUIH also offers masters and doctoral degrees and graduate certificates in acupuncture and Oriental medicine, Ayurveda, health and wellness coaching, herbal medicine, integrative health studies, narrative health, nutrition, and yoga therapy.

About Maryland University of Integrative Health (MUIH)

Maryland University of Integrative Health (MUIH) is a leading academic institution focused on the study and practice of integrative health and wellness and one of the few universities in the U.S. dedicated solely to such practices. Deeply rooted in a holistic philosophy, its model for integrative health and wellness is grounded in whole-person, relationship-centered, evidence-informed care.

Since 1974, MUIH has been a values-driven community educating practitioners and professionals to become future health and wellness leaders through transformative programs grounded in traditional wisdom and contemporary science.

MUIH has more than 20 progressive, graduate degree programs in a wide range of disciplines, offered on-campus and online. In the on-campus Natural Care Center and community outreach settings, MUIH provides compassionate and affordable healthcare from student interns and professional practitioners, which delivers more than 20,000 clinical treatments and consultations each year.

For more information visit http://www.muih.edu.

About American Public Health Association (APHA)

APHA champions the health of all people and all communities. We strengthen the public health profession. We speak out for public health issues and policies backed by science. We are the only organization that combines a nearly 150-year perspective, a broad-based member community, and the ability to influence federal policy to improve the publics health.

For more information visit http://www.apha.org.

Also Read:

Kionne S. Johnson Communications Manager [emailprotected]

Keywords:MUIH, APHA, Educational Parternship, Health, Wellness, Integrative Health, Health Promotion, Science

Read the original here:
Maryland University of Integrative Health announces educational partnership with the American Public Health Association Wall Street Call - Reported...

How Data From Wearables Will Revolutionize Healthcare – Forbes

Posted: at 5:59 pm


I believe that the pandemic will change the way we approach healthcare in the future. Firstly, because this is a dynamic sector that is attracting growing investment around the world as a lot of talented entrepreneurs try to find valid value propositions. Secondly, because it makes perfect sense to try to find patterns that could have prevented the spread of the pandemic: if we had a significant portion of the population monitoring their vital signs on a regular basis in the areas where SARS-CoV-2 first began to infect humans, its very possible that that infection could have been detected and isolated quickly, and that a localized infection would never have escalated into a global pandemic.

Thirdly, because technology is a context variable that establishes the context of our activities, while healthcare is vitally important. It makes no sense for technologies that enable the sensing and control of numerous diagnostic variables to be outside health management systems for too long.

Seen in this light, the fact that clinical studies are beginning to emergein addition to those known as Stanfords with Applein which this type of technology and devices are used satisfactorily is logical, as is the fact that some leading health insurance companies, such as Sanitas in Spain, are beginning to explore this area (link in Spanish).

In order to develop this type of practice, which on the one hand results in greater peace of mind and well-being for the patient and in cost savings in the treatment of many medical conditions on the other, it is essential to create an appropriate legal environment that makes it possible to treat the data generated by the devices responsibly without fearing that they will be misused, marketed or lead to discrimination. In addition, it is important to visualize a scenario in which, regardless of the fact that the first initiatives may arise in the private sphere, their implementation in public health systems can be foreseen, as is in fact beginning to happen in countries such as Singapore, given that both the well-being of the patient and savings on treatment thanks to earlier diagnoses are also likely to generate major advantages.

Wearables are now less about giving hypochondriacs peace of mind and their potential is being fully seen. In the first phase, there might be fears of overloading doctors: the idea of waiting rooms crowded with patients alarmed by such and such a reading on their smartphone is a cause for concern. The logical way forward would instead be for this avalanche of data to be processed by an algorithm with an anomaly detection function, and that only those cases potentially requiring specialized attention would mean a visit to a doctor.

At the same time, we shouldnt forget that a wearable will never be as accurate as a device for clinical use; the advantage of these kinds of devices is that they can gather huge amounts of information 24/7. This progressive reduction of the standard error means that the algorithms for detecting anomalies can work properly, and that a wide range of devices can be used once they have been calibrated and homologated.

This type of environment will also favor the development of more and better research for the future, driving further advances in medical science. Specialties such as cardiology or endocrinology, for example, are in many cases already ahead of that future: the important thing will be to adopt a holistic vision of diagnosis, as elements that can be used in many other areas, and to which other devices will be incorporated.

As technology continues to create boundless new possibilities, the future of medicine will increasingly be about monitoring, data abundance and prevention. The sooner we embrace this, the better.

Go here to read the rest:
How Data From Wearables Will Revolutionize Healthcare - Forbes

First nine months of the year with 1% sales growth at constant exchange rates, significant impact of COVID-19 pandemic – GlobeNewswire

Posted: at 5:59 pm

Commenting on the Groups sales in the first nine months, Roche CEO Severin Schwan said: Roche is at the forefront of the fight against COVID-19 with a growing portfolio of diagnostics solutions, the development of new medicines and a number of partnerships across the industry. With the recent launch of the rapid antigen test, we further strengthened our position as a leading supplier of COVID-19 tests. At the same time, we continue to deliver solutions for patients suffering from other severe diseases. I am particularly pleased about the FDA approvals in the third quarter for three new medicines: Enspryng and Evrysdi for rare diseases, and the cancer medicine Gavreto. After the pandemic-related decline in the second quarter, sales stabilised in the third quarter due to continued strong demand for our new medicines and COVID-19 tests. Based on our current assessment, we confirm the outlook for the full-year.

Roches contributions to the fight against the COVID-19 pandemic in the third quarter:

Outlook confirmed for 2020Based on the current assessment of the COVID-19 impact, sales are expected to grow in the low- to mid-single digit range, at constant exchange rates. Core earnings per share are targeted to grow broadly in line with sales, at constant exchange rates. Roche expects to increase its dividend in Swiss francs further.

Group salesIn the first nine months of 2020, Group sales increased 1% to CHF 44.0 billion.

Sales in the Pharmaceuticals Division decreased 1% to CHF 34.3 billion. Sales grew strongly in the first quarter (+7%). As a result of COVID-19, they decreased in the second quarter (-6%) and since summer first signals of recovery are seen (-4% in the third quarter). Key growth drivers were the cancer medicine Tecentriq, the multiple sclerosis medicine Ocrevus, the haemophilia medicine Hemlibra, Actemra/RoActemra in immunology and Perjeta in breast cancer.

With a strong growth of 35% the new medicines generated sales of CHF 13.7 billion and grew by CHF 3.7 billion at constant exchange rates over 2019, more than offsetting the impact of the competition from biosimilars (sales reduction CHF 3.5 billion at constant exchange rates).

In the US, overall sales decreased 4%. While sales of Ocrevus, Hemlibra, Tecentriq, Actemra/RoActemra and Kadcyla increased, the competition from biosimilars for Herceptin, MabThera/Rituxan and Avastin affected total growth as expected. Ocrevus sales increased by 23% and were driven by both new and returning patient demand but partly impacted by COVID-19 effects. Hemlibra sales increased 68%, resulting from the ongoing rollout in the US. Tecentriq sales increased by 46%, driven by the launch in unresectable hepatocellular carcinoma (HCC) as well as the growth in the new indications extensive stage small cell lung cancer (ES-SCLC) and metastatic triple-negative breast cancer.

In Europe, sales increased 4% as the strong demand for Tecentriq, Ocrevus, Hemlibra, Kadcyla and Perjeta was able to offset the impact of lower sales of Herceptin (-32%), Avastin (-16%) and MabThera/Rituxan (-32%). The first biosimilar versions of Avastin were introduced in Europe in the third quarter of 2020.

In the International region (+6%), growth was mostly driven by Perjeta, Actemra/RoActemra, Alecensa, Tecentriq and Ocrevus, partially offset by the impact of the National Reimbursement Drug List update in China and COVID-19.

Sales decreased in Japan (-6%) as a result of the considerable competition from biosimilars, generics, COVID-19 and government price cuts. This decline was partially compensated by recently launched products including Tecentriq and Hemlibra.

The Diagnostics Division recorded very strong sales growth of 9% to CHF 9.7 billion, with particularly strong growth of 18% in the third quarter. After a 5% increase in the first quarter, momentum slowed to 2% growth in the second quarter as a result of the pandemic. The overall very strong sales growth is primarily due to the industry-leading portfolio of new COVID-19 tests. The Molecular Diagnostics business made the largest contribution (+77%) with PCR tests for COVID-19. Sales of diagnostic solutions for SARS-CoV-2 developed only this year clearly exceeded COVID-19 related declines in routine diagnostics sales. Additional product launches in the third quarter, including the SARS-CoV-2 antigen rapid test, further strengthened Roche's position as the world's leading supplier of COVID-19 tests.

Growth was reported in North America (+22%), EMEA3 (+9%), Latin America (+12%) and Japan (+5%). In the Asia-Pacific region (-4%), sales were heavily impacted by the pandemic, especially in China. Overall, demand was impacted by COVID-19 in all regions since the second quarter. Routine testing decreased significantly due to a decline in regular health checks while emergency and SARS-CoV-2 testing increased significantly.

Roches contributions to the fight against the COVID-19 pandemicIn September, the Elecsys Anti-SARS-CoV-2 S antibody test was launched for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the FDA. The Elecsys Anti-SARS-CoV-2 S immunology test, which targets antibodies against the spike protein, can be used to quantitatively measure antibodies in people who have been exposed to SARS-CoV-2 and can play an important part in characterising a vaccine-induced immune response. The majority of current candidate vaccines aim to induce an antibody response against the spike protein of the virus.

In the same month, Roche received an EUA from the FDA for its cobas SARS-CoV-2 & Influenza A/B test for use on the cobas 6800/8800 Systems. This test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A and influenza B in patients suspected by their healthcare provider of having a respiratory viral infection; it is also available in markets accepting the CE Mark.

For urgent and emergency care settings, Roche also received EUA from the FDA in September for the cobas SARS CoV-2 & Influenza A/B test on the cobas Liat System, which provides results in 20 minutes.

Roche also launched the SARS-CoV-2 rapid antigen test in markets accepting the CE Mark and plans to submit files for an EUA with the FDA. The SARS-CoV-2 rapid antigen test is for use in point of care settings for symptomatic people. This can help healthcare professionals identify a SARS-CoV-2 infection in people suspected of carrying the virus with results typically ready in 15 minutes. In addition, it serves as a valuable initial screening test for individuals who have been exposed to SARS-CoV-2-infected patients or in a high-risk environment.

Roche also announced that it intends to launch a high-volume SARS-CoV-2 Antigen test as an aid in the diagnosis of SARS-CoV-2 infection. The test is planned to be made available at the end of 2020 for markets accepting the CE Mark. Roche also intends to file for EUA from the FDA. The test is performed by healthcare professionals and uses swab samples from patients with signs and symptoms suggestive of COVID-19, or people with either known or suspected exposure to SARS-CoV-2.

The portfolio of our recently developed SARS-CoV-2 tests as well as our existing diagnostics menu for critical care have become a significant factor in supporting patient management during the COVID-19 pandemic. Roche has already increased its overall production of tests fourfold over the usual volumes and has committed significant funds to continue expanding productions capacity for PCR tests over the coming year. Our investments are expected to result in more than 1,000 new jobs in the US and Europe.

The phase III Empacta study met its primary endpoint, showing that patients with COVID-19 associated pneumonia who received Actemra/RoActemra plus standard of care were 44% less likely to progress to mechanical ventilation or death compared to patients who received placebo plus standard of care. The cumulative proportion of patients who progressed to mechanical ventilation or death by day 28 was 12.2% in the Actemra/RoActemra arm versus 19.3% in the placebo arm. There was no statistical difference in mortality between patients who received Actemra/RoActemra or placebo by day 28. Approximately 85% of the 389 patients were from minority racial and ethnic groups. The trial was conducted in Brazil, Kenya, Mexico, Peru, South Africa and the USA.

In August, Roche and Regeneron joined forces in the fight against COVID-19 to develop, manufacture and distribute REGN-COV2, Regenerons investigational antiviral antibody cocktail. Regeneron has submitted a request to the FDA for an Emergency Use Authorization (EUA) for REGN-COV2. Initial data from the REGN-COV2 phase II portion of an ongoing study showed a reduction in viral load, an acceleration of symptom alleviation and a decrease in medical visits in non-hospitalised patients with COVID-19. Additional data from this study are expected by the end of 2020. We will be working with health authorities and global health institutions in a concerted, collective response, with the aim of achieving broad approvals.

Drug launches, filings, pivotal phase III trial readouts and pivotal trial starts planned by the Roche Group are largely on track.

The Covacta study of Actemra/RoActemra did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe COVID-19-associated pneumonia. In addition, the key secondary endpoints, which included the difference in patient mortality at week four, were not met; however, there was a positive trend in time to hospital discharge in patients treated with Actemra/RoActemra. This study generated robust information which will help physicians make decisions about the treatment of patients with this disease.

Overview of Roche Diagnostics COVID-19 diagnostic solutions developed in the first nine months of 2020

Regulatory achievements in the third quarterRegulators around the globe granted approvals for new Roche medicines, line extensions of existing medicines and new tests.

The FDA approved Evrysdi (risdiplam), an oral medication for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months of age and older. Evrysdi showed clinically meaningful improvements in motor function across two clinical trials in people with varying ages and levels of disease severity, including types 1, 2, and 3 SMA. Evrysdi also improved survival without permanent ventilation at 12 and 23 months of treatment, compared to natural history.

FDA approval was granted for Enspryng (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with anti-aquaporin-4 (AQP4) antibody positive neuromyelitis optica spectrum disorder (NMOSD). NMOSD is a rare, lifelong and debilitating autoimmune disorder of the central nervous system, often misdiagnosed as multiple sclerosis, that primarily damages the optic nerve(s) and spinal cord, causing blindness, muscle weakness and paralysis. Enspryng demonstrated significant reduction in the risk of relapse compared with placebo as a monotherapy and when used concurrently with baseline immunosuppressant therapy.

The FDA also approved Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer as detected by an FDA approved test. This indication was approved under the FDAs Accelerated Approval programme, based on data from the phase I/II ARROW study. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

The European Commission granted conditional marketing authorisation for Rozlytrek for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and who have not received a prior NTRK inhibitor and who have no satisfactory treatment options. The European Commission has also approved Rozlytrek for the treatment of adults with ROS1-positive, advanced non-small cell lung cancer (NSCLC) not previously treated with ROS1 inhibitors.

The FDA also granted approval for Tecentriq plus Cotellic and Zelboraf for the treatment of BRAF V600 mutation-positive advanced melanoma patients.

In Japan, Tecentriq in combination with Avastin, was approved by the Ministry of Health, Labour and Welfare for the treatment of unresectable hepatocellular carcinoma.

The FoundationOne Liquid companion diagnostic test (F1L CDx) received FDA approval. Furthermore, the comprehensive liquid biopsy service received the CE Mark in May. Both regulatory milestones allow for the new test to be commercialised in all markets that recognise the CE Mark and/or the FDA approval. F1L CDx is the most comprehensive pan-tumour liquid biopsy test for all solid tumours, incorporating multiple companion diagnostics. This test supports efforts to improve treatment results by helping oncologists optimise and personalise treatment for their patients with advanced cancer during all lines of therapy, and particularly for those where tissue-based testing is not possible.

Additional regulatory achievements in the third quarter of 2020:

Diagnostics key launches in the third quarter In addition to the new COVID-19 portfolio, Roche received FDA approval for the Ventana HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2 biomarker in breast cancer and as a companion diagnostic for Herceptin therapy. HER2 - human epidermal growth factor receptor 2 - is an important biomarker sometimes found in breast cancers. Its detection and inhibition can help healthcare professionals manage this aggressive cancer more effectively. This new assay is designed to be completed within the same day, enabling clinicians to get results back faster than with other common methods of confirmatory testing for HER2. Results can be read using light microscopy, eliminating the need for a specialised fluorescence microscope.

The FDA also authorised the cobas EBV test, the first quantitative in vitro diagnostic test for Epstein-Barr virus (EBV) DNA in the US. The test meets World Health Organization standards for consistent result reporting among laboratories across the US, allowing for results to be easily comparable across hospitals and laboratories. Monitoring of Epstein-Barr virus DNA can help prevent the progression of life-threatening diseases such as cancer in transplant patients.

Roche also received FDA clearance for the BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients. The test provides standardised, high-quality results that can help healthcare professionals better assess the risk of complications caused by the BK virus in transplant patients and identify effective treatment options.

In August, the FDA approved the cobas HIV-1/HIV-2 qualitative test for use on the fully automated cobas 6800/8800 Systems in the US. The test provides healthcare professionals with a single result to confirm HIV diagnosis and differentiate HIV-1 and HIV-2, an important distinction needed to identify appropriate treatment options.

In September, Roche launched the Elecsys HIV Duo immunoassay in the US, following FDA approval in April 2020. Through separate measurement of the HIV p24 antigen (the virus) and anti-HIV antibodies (caused by immune reaction), this test can detect an acute HIV infection earlier than current methods. This approval enables a robust, comprehensive infectious diseases menu on the cobas e 801 system and a significant step towards bringing holistic value to the US market within the area of infectious diseases.

Roche announced FDA approval in September for the expanded use of CINtec PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions on which women will benefit most from immediate follow-up. Laboratories can now use CINtec PLUS Cytology to triage positive results from the cobas HPV Test run on the fully integrated, automated and high-throughput cobas 6800/8800 Systems.

Key development milestones in the third quarter of 2020Regulatory filings and product launches for 2020 as well as pivotal trial read-outs and pivotal starts in 2020 are largely on track. We are making significant efforts to protect all studies with continued support from health authorities, but the ultimate outcome will depend on the length and severity of the pandemic.

Results from the phase III IMpassion031 study, evaluating Tecentriq in combination with chemotherapy (Abraxane, albumin-bound paclitaxel; nab-paclitaxel; followed by doxorubicin and cyclophosphamide) in comparison with placebo plus chemotherapy (including nab-paclitaxel), demonstrated a statistically significant and clinically meaningful improvement in pathological complete response (pCR) for the treatment of people with early TNBC, regardless of PD-L1 expression. The IMpassion031 study is the second positive phase III study from Roche to demonstrate the benefit of Tecentriq in TNBC and the first Tecentriq study to demonstrate a benefit in early TNBC.

The final overall survival (OS) analysis of the phase III IMpassion130 study, evaluating Tecentriq in combination with nab-paclitaxel, compared with placebo plus nab-paclitaxel, as a first-line treatment for patients with metastatic TNBC, was consistent with the first and second interim analyses. There was no significant difference in OS between the treatment groups in the ITT population. Clinically meaningful improvements of 7.5 months in median OS were seen with Tecentriq plus nab-paclitaxel in PD-L1-positive patients.

Detailed results from the phase III Archway study showed that 98.4% of Port Delivery Systems (PDS) patients were able to go six months without needing additional treatment and achieved vision outcomes equivalent to patients receiving monthly ranibizumab eye injections, a current standard of care. This study evaluates the investigational Port Delivery System with ranibizumab for the treatment of neovascular or wet age-related macular degeneration (nAMD), a leading cause of blindness globally.

New two-year data from part 1 of the pivotal Firefish study of Evrysdi in infants aged two to seven months with symptomatic Type 1 SMA showed that infants treated with the therapeutic dose of Evrysdi (17/21) continued to improve and achieve motor milestones.

Pharmaceuticals Division

Key pharmaceutical productsAvastin (-22%). For advanced colorectal, breast, lung, kidney, cervical and ovarian cancer, and relapsed glioblastoma (a type of brain tumour). Sales were impacted by the biosimilar competition in the US, Europe and Japan.

MabThera/Rituxan (-27%). For forms of blood cancer, rheumatoid arthritis and certain types of vasculitis. The sales decline was driven by all regions, due to the launch of biosimilars in the US and most EU markets and in Japan.

Herceptin (-31%). For HER2-positive breast cancer and HER2-positive metastatic gastric cancer. Sales were impacted by biosimilars in the US, Europe and Japan. In the US, the switch to Kadcyla in the adjuvant setting also impacted sales.

Actemra/RoActemra (+33%). For rheumatoid arthritis, forms of juvenile idiopathic arthritis and giant cell arteritis as well as CAR T cell-induced severe or life-threatening cytokine release syndrome. A number of countries included Actemra/RoActemra in their treatment guidelines for severe COVID-19 pneumonia. Actemra/RoActemra is not currently approved for this use; Roche is conducting several phase III clinical studies. The US and the International region were the major contributors to the sales increase.

Xolair (+2%, US only). For chronic idiopathic urticaria and allergic asthma. The sales increase was driven by the demand in both indications. Xolair remains the market leader in the larger allergic asthma indication.

Lucentis (-14%, US only). For eye conditions, including neovascular (wet) age-related macular degeneration, macular oedema following retinal vein occlusion, diabetic macular oedema, and diabetic retinopathy. Sales decreased in all approved indications and were especially affected by the COVID-19 pandemic due to disruptions in hospitals and ophthalmology practices and many patients delaying treatment during restrictions.

Highlights for medicines launched since 2012Ocrevus (first approved in 2017; CHF 3.3 billion, +29%). For the treatment of both the relapsing (RMS) and primary progressive (PPMS) forms of multiple sclerosis (MS). The strong demand for this treatment in both indications has continued, while the COVID-19 pandemic has had a certain negative impact. In the US, growth was driven both by new and returning patients, with a higher proportion of sales coming from returning patients. In Europe and the International region, Ocrevus continues to show strong initial uptake where launched.

Perjeta (first approved in 2012; CHF 2.9 billion, +17%). As therapy for HER2-positive breast cancer. Sales grew strongly in the International region. The increased patient demand for Perjeta for adjuvant early breast cancer therapy supports its continued strong growth.

Tecentriq (first approved in 2016; CHF 2.0 billion, +64%). Approved either alone or in combination with targeted therapies and/or chemotherapies in various forms of NSCLC, in small cell lung cancer (SCLC), certain types of metastatic urothelial cancer, and in PD-L1-positive metastatic TNBC. In the US and several other countries, Tecentriq in combination with Avastin is approved for people with unresectable or metastatic HCC and in the US and two other countries Tecentriq is approved in combination with Cotellic and Zelboraf for the treatment of people with BRAF V600 mutation-positive advanced melanoma. Strong sales growth was reported by all regions, driven mainly by the indications in ES-SCLC and TNBC. Sales in Japan increased due to robust uptake in first-line NSCLC and first-line ES-SCLC.

Hemlibra (first approved in 2017; CHF 1.6 billion, +79%). For treating people with haemophilia A with factor VIII inhibitors. It is also approved to treat people with haemophilia A without factor VIII inhibitors. Hemlibra is the only prophylactic treatment that can be administered subcutaneously and with multiple dosing options (once weekly, once every two weeks or once every four weeks). Sales continued to show a strong uptake in all regions, despite COVID-19 restrictions having some impact on potential new patients.

Kadcyla (first approved in 2013; CHF 1.3 billion, +37%). For treating HER2-positive breast cancer. The increased demand for Kadcyla was driven by its usage in the early breast cancer setting. Sales benefited from the positive read-out from the Katherine study and patients switching to the new standard of treatment.

Esbriet (first approved in 2014; CHF 844 million, +9%). For idiopathic pulmonary fibrosis. Sales continued to expand, driven by growth in the US and Europe.

Alecensa (first approved in 2015; CHF 841 million, +35%). To treat ALK-positive lung cancer. Alecensa showed continued sales growth across all regions.

Gazyva/Gazyvaro (first approved in 2013; CHF 472 million, +27%). For chronic lymphocytic leukaemia (CLL), rituximab-refractory follicular lymphoma and previously untreated advanced follicular lymphoma. Sales increased in all regions.

Polivy (first approved in 2019; CHF 126 million, +>500%). Part of combination therapy for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma.

Xofluza (first approved in 2018; CHF 28 million, +286%). For the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older and people with high risk of developing flu-related complications.

Rozlytrek (first approved in 2019; CHF 15 million, +319%). For a specific form of NSCLC and for solid tumours expressing a specific gene fusion. In Japan, Rozlytrek was approved for treatment of ROS1 fusion- positive NSCLC.

Evrysdi (risdiplam, first approved in 2020; CHF 8 million*4). For the treatment of spinal muscular atrophy (SMA) in adults and children two months of age and older.

Phesgo (fixed-dose combination of Perjeta and Herceptin with hyaluronidase, first approved in 2020; CHF 7 million*). For the treatment of early and metastatic HER2-positive breast cancer by subcutaneous injection (SC) administered in combination with intravenous chemotherapy.

Enspryng (satralizumab, first approved in 2020; CHF 7 million*). For a rare neurodegenerative disease (neuromyelitis optica spectrum disorder).

Diagnostics Division

In the first nine months 2020, COVID-19 and emergency testing strongly increased while routine testing decreased as a result of continued declining or delayed regular health checks and medical appointments. Nevertheless, Roches broad, diversified test portfolio and its large number of instruments installed worldwide provided for a strong sales growth.

During 2020, Roche has increased its production capacity (reagents and consumables) for COVID-19 testing massively. This includes all our products used in fighting COVID-19 infections.

Centralised and Point of Care Solutions sales declined by 7%, its immunodiagnostics business (-8%) was strongly impacted by the COVID-19 impact on routine testing worldwide. COVID-19 related products such as the Elecsys Anti-SARS-CoV-2 test, Custom Biotech, Elecsys IL-6 test and the SARS-CoV-2 rapid antigen test partly offset the COVID-19 impact.

Sales in Molecular Diagnostics increased 77%, with 88% growth in the underlying molecular business. Growth was driven by virology (predominantly SARS-CoV-2), Quantitative PCR (to detect molecular/genetic targets) and Nucleic Acid Purification (to isolate and purify genetic material), Molecular Diagnostics systems, Molecular Point-of-Care (influenza viruses).

Diabetes Care sales decreased 2%, with the continued contraction of the Blood Glucose Monitoring (BGM) market due to patients switching to Continuous Glucose Monitoring (CGM) systems. The COVID-19 pandemic also had an impact. The decrease was reflected mainly in the EMEA region, notably in Germany, UK and Italy. The positive uptake of digital diabetes management solutions continued: AccuChek SugarView, RocheDiabetes Care Platform and mySugr.

Tissue Diagnostics sales increased 5%, supported by advanced staining, instrument sales and companion diagnostics business. However, overall sales were impacted by the COVID-19 pandemic.

About RocheRoche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve peoples lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the worlds largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in R&D and posted sales of CHF 61.5 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit http://www.roche.com.

All trademarks used or mentioned in this release are protected by law.

References[1] Unless otherwise stated, all growth rates in this document are at constant exchange rates (CER: average 2019).[2] Launched since 2012: Erivedge, Perjeta, Kadcyla, Gazyva, Esbriet, Cotellic, Alecensa, Tecentriq, Ocrevus, Hemlibra, Xofluza, Polivy, Rozlytrek, Phesgo, Enspryng, Evrysdi[3] EMEA = Europe, Middle East and Africa[4] recently launched, no growth figures available

Cautionary statement regarding forward-looking statementsThis Annual Report contains certain forward-looking statements. These forward-looking statements may be identified by words such as believes, expects, anticipates, projects, intends, should, seeks, estimates, future or similar expressions or by discussion of, among other things, strategy, goals, plans or intentions. Various factors may cause actual results to differ materially in the future from those reflected in forward-looking statements contained in this Annual Report, such as: (1) pricing and product initiatives of competitors; (2) legislative and regulatory developments and economic conditions; (3) delay or inability in obtaining regulatory approvals or bringing products to market; (4) fluctuations in currency exchange rates and general financial market conditions; (5) uncertainties in the discovery, development or marketing of new products or new uses of existing products, including without limitation negative results of clinical trials or research projects, unexpected side effects of pipeline or marketed products; (6) increased government pricing pressures; (7) interruptions in production; (8) loss of or inability to obtain adequate protection for intellectual property rights; (9) litigation; (10) loss of key executives or other employees; and (11) adverse publicity and news coverage.

The statement regarding earnings per share growth is not a profit forecast and should not be interpreted to mean that Roches earnings or earnings per share for 2020 or any subsequent period will necessarily match or exceed the historical published earnings or earnings per share of Roche.Roche Group Media RelationsPhone: +41 61 688 8888 / e-mail: media.relations@roche.com

Follow this link:
First nine months of the year with 1% sales growth at constant exchange rates, significant impact of COVID-19 pandemic - GlobeNewswire

The role of mHealth and digitisation in diabetes care – Med-Tech Innovation

Posted: at 5:59 pm

Martin Gerber, global head of innovation at Ascensia Diabetes Care, writes about the use of digital health technology in helping treating diabetes patients.

The number of mobile health (mHealth) apps continues to soar year on year, with more than 300,000 currently available on iOS and Android compared with the approximately 165,000 available in 2015.

Digital tools such as apps are becoming increasingly important for the 463 million people across the globe with diabetes, helping many to manage their condition. But as mHealth becomes more established in healthcare and as adoption is accelerated by the ongoing COVID-19 pandemic, we need to consider how to optimise its impact for all.

mHealth and diabetes care

Most people with diabetes (PWDs) only see their healthcare professional (HCP) for a few hours each year, making the majority of care self-management. Its therefore no surprise that there are approximately 2,000 apps in the US alone related to supporting people with diabetes. Crucially, in the absence of regular facetime with HCPs, some of these apps enable PWDs to monitor their diabetes management, identify patterns and trends, and share data with their HCPs when they need more input.

These mHealth apps play a key role in self-management and there is evidence to show they really do work. For example, we found in a study from 2018 that using Ascensias Contour Diabetesapp for over 180 days was associated with a reduced frequency of both hypoglycaemic and hyperglycaemic events.

Furthermore, apps can provide vital support in driving long-term behavior change in areas such as nutrition, activity and sleep that not only improve diabetes but also its related comorbidities. This is where digital health solutions have great potential to offer holistic approaches that deliver sustainable, optimal health outcomes.

Creating a holistic ecosystem

It is key to keep in mind that mHealth apps cannot be used in isolation they must be employed as part of a holistic healthcare ecosystem.

Digital health is about connecting the dots between different devices, conditions and treatments as well as between patients and HCPs. As a result, partnerships and collaborations play a crucial role. From digital health start-ups to healthcare providers, organisations need to ensure that their devices and systems integrate together if they are to improve the quality of life for those that depend on them.

As an example, for PWDs this could include enabling data integration from multiple sources such as CGMs, ECGs, and other wearables into the same app or digital solution. From this, treatments and management advice can be tailored to the bespoke needs of the patient.

A data driven society

In todays society, data drives many of the biggest discoveries and healthcare is no exception. Huge advances in technology are now arming HCPs and patients with vast amounts of data and its becoming apparent that this is leading to better health insights.

The future of diabetes management, for example, is more than just devices and medications. Collecting and analysing data to provide actionable, personalised management recommendations is critical to improving the health and lives of PWDs. Yet less than 1% of mHealth apps related to diabetes in the US have more than 50,000 monthly active users (MAUs), and less that 10% of mHealth apps across the board have exceeded this level either.

The challenges for developers offering mHealth apps remain unchanged: how to engage, re-engage, and retain regular users.

From app recruitment to retention

Some fundamental barriers to app usage are harder to address than others. Around the world many people dont have access to the necessary technology, such as smartphones and laptops. This is further compounded by digital and health literacy issues that create a serious barrier to virtual diabetes care.

It is imperative for apps to retain those who do have access as they can improve a persons engagement in their care. In a study we found that engagement with diabetes self-management increased over time, as demonstrated by frequency of blood glucose testing after 180 days of app use versus 30 days. In other words, long-term use of a mHealth app seems to facilitate higher engagement by people with chronic conditions and, in turn, this can lead to better self-management.

The user journey is generally the most influential factor when considering how best to retain and engage users. Apps must fit into the lifestyles of those managing chronic conditions and listening to users is paramount in establishing what features matter. This is where user centred design and frequent usability studies become critical to the development process.

In healthcare, needs vary from person to person, through gender, age and socioeconomic situation. A truly personalised user experience goes beyond medicine in order to drive engagement, and ultimately improve quality of life.

For the health ecosystem to really thrive, we need to increase access to mHealth and enable better collaboration that can optimise digitisation. We are starting to see this in abundance in diabetes care and we are very excited to see this transformation stretch above and beyond diabetes management.

Read this article:
The role of mHealth and digitisation in diabetes care - Med-Tech Innovation

President Trumps doctor is a D.O, not an M.D. Whats the difference? – Tampa Bay Times

Posted: October 10, 2020 at 7:49 am

Dr. Katherine Pannel was initially thrilled to see President Donald Trumps physician is a doctor of osteopathic medicine. A practicing D.O. herself, she loved seeing another glass ceiling broken for the type of doctor representing11% of practicing physiciansin the U.S. and now1 in 4 medical studentsin the country.

But then, as Dr. Sean Conley issued public updates on his treatment of Trumps COVID-19, the questions and the insults about his qualifications rolled in.

How many times will Trumps doctor, who is actually not an MD, have to change his statements? MSNBCs Lawrence ODonnelltweeted.

It all came falling down when we had people questioning why the president was being seen by someone that wasnt even a doctor, Pannel said.

The osteopathic medical field has had high-profile doctors before, good and bad. Dr. Murray Goldstein was the first D.O. to serve as a director of an institute at the National Institutes of Health, and Dr. Ronald R. Blanck was the surgeon general ofthe U.S. Army. Former Vice President Joe Biden, challenging Trump for the presidency, alsosees a doctor who is a D.O.But another now former D.O., Larry Nassar, who was the doctor for USA Gymnastics, was convicted of serial sexual assault.

Still, with this latest example, Dr. Kevin Klauer, CEO of the American Osteopathic Association, said hes heard from many fellow osteopathic physicians outraged that Conley and by extension, they, too are not considered real doctors.

You may or may not like that physician, but you dont have the right to completely disqualify an entire profession, Klauer said.

For years, doctors of osteopathic medicine have been growing in number alongside the better-known doctors of medicine, who are sometimes called allopathic doctors and use the M.D. after their names.

According to theAmerican Osteopathic Association, the number of osteopathic doctors grew 63 percent in the past decade and nearly 300 percent over the past three decades. Still, many Americans dont know much about osteopathic doctors, if they know the term at all.

There are probably a lot of people who have D.O.s as their primary (care doctor) and never realized it, said Brian Castrucci, president and CEO of the de Beaumont Foundation, a philanthropic group focused on community health.

Both types of physicians can prescribe medicine and treat patients in similar ways.

Although osteopathic doctors take adifferent licensing exam, the curriculum for their medical training four years of osteopathic medical school is converging with M.D. training as holistic and preventive medicine becomes more mainstream. And starting this year, both M.D.s and D.O.s were placed into one accreditation pool to compete for the same residency training slots.

But two major principles guiding osteopathic medical curriculum distinguish it from the more well-known medical school route: the 200-plus hours of training on the musculoskeletal system and the holistic look at medicine as a discipline that serves the mind, body and spirit.

The roots of the profession date to the 19th century and musculoskeletal manipulation. Pannel was quick to point out the common misconception that their manipulation of the musculoskeletal system makes them chiropractors. Its much more involved than that, she said.

Dr. Ryan Seals, who has a D.O. degree and serves as a senior associate dean at the University of North Texas Health Science Center in Fort Worth, said that osteopathic physicians have a deeper understanding than allopathic doctors of the range of motion and what a muscle and bone feel like through touch.

That said, many osteopathic doctors dont use that part of their training at all: A 2003 Ohio study said approximately75%of them did not or rarely practiced osteopathic manipulative treatments.

The osteopathic focus on preventive medicine also means such physicians were considering a patients whole life and how social factors affect health outcomes long before the pandemic began, Klauer said. This may explain why 57 percent of osteopathic doctorspursue primary carefields, as opposed to nearly a third of those with doctorates of medicine, according to theAmerican Medical Association.

Pannel pointed out that shes proud that42 percentof actively practicing osteopathic doctors are women, as opposed to36 percentof doctors overall. She chose the profession as she felt it better embraced the whole person, and emphasized the importance of care for the underserved, includingrural areas. She and her husband, also a doctor of osteopathic medicine, treat rural Mississippi patients in general and child psychiatry.

Given osteopathic doctors' likelihood of practicing in rural communities and of pursuing careers in primary care,Health Affairsreported in 2017, they are on track to play an increasingly important role in ensuring access to care nationwide, including for the most vulnerable populations.

To be sure, even though the physicians end up with similar training and compete for the same residencies, some residency programs have often preferred M.D.s, Seals said.

Traditional medical schools have held more esteem than schools of osteopathic medicine because of their longevity and name recognition. Most D.O. schools have been around for only decades and often are in Midwestern and rural areas.

While admission to the nations37 osteopathic medical schoolsis competitive amid a surge of applicants, thegrade-point average and Medical College Admission Test scoresareslightly higherfor the155 U.S. allopathic medical schools: Theaverage MCATwas 506.1 out of 528 for allopathic medical school applicants over a three-year period, compared with 503.8 for osteopathic applicants for 2018.

Seals said prospective medical students ask the most questions about which path is better, worrying they may be at a disadvantage if they choose the D.O. route.

Ive never felt that my career has been hindered in any way by the degree, Seals said, noting that he had the opportunity to attend either type of medical school, and osteopathic medicine aligned better with the philosophy, beliefs and type of doctor he wanted to be.

Many medical doctors came to the defense of Conley and their osteopathic colleagues, including Dr. John Morrison, an M.D. practicing primary care outside of Seattle. He was disturbed by the elitism on display on social media, citing the skills of the many doctors of osteopathic medicine hed worked with over the years.

There are plenty of things you can criticize him for, but being a D.O. isnt one of them, Morrison said.

Lauren Weber is Midwest correspondent for Kaiser Health News, a nonprofit news service covering health issues. It is an editorially independent program of KFF (Kaiser Family Foundation), which is not affiliated with Kaiser Permanente.

HOW CORONAVIRUS IS SPREADING IN FLORIDA: Find the latest numbers for your county, city or zip code.

FACE MASKS: Read the latest on guidelines, tips for comfort and long-term wear

GET THE DAYSTARTER MORNING UPDATE: Sign up to receive the most up-to-date information.

THE CORONAVIRUS SCRAPBOOK: We collected your stories, pictures, songs, recipes, journals and more to show what life has been like during the pandemic.

A TRIBUTE TO THE FLORIDIANS TAKEN BY THE CORONAVIRUS: They were parents and retirees, police officer and doctors, imperfect but loved deeply.

HAVE A TIP?: Send us confidential news tips

Were working hard to bring you the latest news on the coronavirus in Florida. This effort takes a lot of resources to gather and update. If you havent already subscribed, please consider buying a print or digital subscription.

Read more:
President Trumps doctor is a D.O, not an M.D. Whats the difference? - Tampa Bay Times

Spice Lab Tokyo: Defying expectations of Indian-Japanese fusion cuisine – The Japan Times

Posted: at 7:49 am

At first, the concept behind Spice Lab Tokyo, which seeks to marry the cuisines of India and Japan, sounds like an intriguing but improbable proposition. Indian cooking, with its pantheon of spices, relies on the kaleidoscopic layering of flavors, while the Japanese kitchen emphasizes simplicity. How can one balance the maximalist complexity of Indian recipes with Japanese cuisines understated grace?

For executive chef Tejas Sovani, 34, the answer is straightforward, but far from easy: The task requires time, effort and above all patience. Its a lesson he gleaned during an apprenticeship at restaurant Noma in Copenhagen five years ago.

At Noma, there may be hundreds of trials before a dish ever makes it to the table. I learned to never give up, and thats helped me put the cuisine (at Spice Lab) together, he says, explaining that the training taught him to consider food culture from various perspectives.

After Denmark, he returned to India later that year to helm restaurant Amaranta in Delhis The Oberoi Gurgaon, where he gained praise for his innovative take on Indian fine dining, before relocating to Japan last year to lead the team at Spice Lab. His experience at Noma, Sovani says, prepared him for his new role in Tokyo by teaching him how to cope in an unfamiliar environment.

The concepts and ingredients seemed so foreign and difficult, the soft-spoken and unfailingly polite chef recalls. Initially, I felt discouraged, but I knew that I had to face my fears.

This ability to overcome uncertainty came in handy when he moved to Tokyo, where he encountered cultural differences and a language barrier. But Sovanis more daunting challenge was introducing a new category of cuisine in one of the worlds most demanding markets, where there is not only an expectation of quality, but pre-existing ideas of Indian food as something that is primarily casual.

Guests come and expect it to be completely Indian, but when they hear the story, they realize its very different. They relate to the Japanese ingredients and understand that its a global cuisine, Sovani says, noting that the curries and naan typically associated with South Asian restaurants are intentionally absent at Spice Lab.

Spices and simplicity: Spice Lab Tokyos concept is modern Indian cuisine that blends aspects from both India and Japan. | COURTESY OF SPICE LAB TOKYO

He credits the restaurants success to the support of its international team in particular, sous chef Akira Himukai, who provides valuable insight as a Japanese chef. Before launching, Himukai spent a month in India studying the food culture, and he and Sovani experimented with Japanese techniques and ingredients from Japan.

Balance is incredibly difficult because the approach is totally different in both cuisines. If you try to bring out the flavor of the ingredient, then you might lose the impact of the spices; but if you push the flavor of the spices, you kill the natural flavor of the ingredients, Himukai says.

Continuous trial and error is the key to Sovanis recipe development. Dishes start with an idea taken from Indian regional cuisine or culture for example, street food in Mumbai or Ayurvedic holistic medicine and incorporate seasonal local ingredients, along with elements from the Japanese kitchen, such as miso, or the technique of marinating seafood between blades of konbu kelp.

So many dishes have bombed completely, Sovani says with a laugh, describing an experiment of spiny lobster flavored with sweet miso and tomato, then topped with sea urchin and caviar. It was like a crowded street in Delhi. That might work in India, but not for this audience.

On a visit to Spice Lab in September, the first bite tomato gelee with pickled cucumber and salted kelp, crowned with a sliver of deep-fried curry leaf demonstrates the principles of universal deliciousness: a balanced mouthful of umami and acidity, with a hit of spice and fat from the curry leaf. Another dish of mustard-marinated ayu (sweetfish) served with a smear of tade (water pepper) herb paste, inspired by the cuisine of Kerala on Indias southwestern coast, is an unexpected and delicious riff on a classic Japanese summer delicacy.

In October, the autumn menu explores other regions and traditions of the Indian subcontinent. A plump grilled prawn, resting in a pool of chili- and coconut-scented bisque, pays homage to the former French settlement of Pondicherry and the areas interpretation of bouillabaisse. Roasted guinea fowl brushed with savory-sweet teriyaki sauce, alongside maitake mushroom and a sauce enriched with warm spices and ground sesame seeds, reimagines the game meat-heavy royal cuisine of northern India. Sovanis classical French training ties everything together with a ribbon of finesse. In a nod to Japanese food culture, the meal ends with rice: Clay pot-cooked biryani is steamed with a fragrant medley of mushrooms and accompanied by three sauces.

Apart from a handful of chefs such as Gaggan Anand of the now-closed Michelin-starred restaurant Gaggan in Bangkok few have attempted to combine Indian and Japanese cuisine, but Sovani makes a convincing case for it. Spice Lab celebrates its first anniversary in November, and the restaurant is sure to develop in ways that further challenge perceptions of Indian food.

The word evolution is very important. Cuisine has to adapt so that it can survive, Sovani says. Ours is a restaurant that is very much of this time and of this place.

Gicros Ginza Gems 10F, Ginza 6-4-3, Chuo-ku, Tokyo 104-0061; 03-6274-6821; spicelabtokyo.com; open 11:30 a.m.-2 p.m. (L.O.), 6-9 p.m. (L.O.); lunch from 2,900, dinner from 8,800

In line with COVID-19 guidelines, the government is strongly requesting that residents and visitors exercise caution if they choose to visit bars, restaurants, music venues and other public spaces.

Excerpt from:
Spice Lab Tokyo: Defying expectations of Indian-Japanese fusion cuisine - The Japan Times

A Physicians Guide to Balance: Yoga will save the WorldIf only People do it – APN News

Posted: at 7:49 am

Published on October 9, 2020

Source pninews.com

By Dr Steven Landau, MD, USA

I couldnt practice medicine without doing meditation and yoga.

I began doing yoga at the age of 10. I thought to myself, This will save the world! after finishing a brief rest in the corpse pose. Then the second thought came, If only people will do it. (Aye, theres the rub.) Then I stopped doing it.

I started doing meditation regularly in Harvard in my senior year of undergraduate training. It helped calm my mind, and Ive been doing it ever since, with the Ananda Marga Yoga Society. Now I teach classes in prisons, battered womens shelters, and my own Johnston Memorial Hospital. I even have a straight scientific talk I do for CME on Medical Aspects of Yoga and Meditation. And youre probably wondering what all those initials mean after my MD. The FAAFP is a symbol of family practice, the primary holistic discipline in mainstream medicine. The ABHM is the sign of the even more holistic discipline in non-mainstream medicine, the American Board of Holistic Medicine. The RYT stands for Registered Yoga Teacher.

I was asked to do this article because of my association with the Yoga Alliance, a non-profit group of idealistic and practical yoga teachers who also want to save the world through yoga. Theyve set up minimum standards of training in this art and science that was previously almost totally unregulated, and is still usually taught from master to disciple.

Have you noticed how much Ive used the word I so far? Thats a little like the practice of meditation. First you get the I trash out, and after a while it all gets handled nicely. Then, as your selfish concerns wear off, you start getting the larger picture and transcend into the realm of bliss.

Ashtanga (8-limbed) yoga incorporates the multiple elements used to put out the trash and keep it out. It has parallels to medicine, as follows:

1. YAMA (intro-external controls)

a. Ahimsanoninjury by thought, word, or deed (First, do no harm).

b. Asteyaabandoning the thought of stealing or of depriving someone of their due (keeps me clear of Medicare fraud).

c. Satyabenevolent truthfulnessaction of mind in the right use of words with the spirit of welfare (the art of medicine: what do I tell, to whom, and when? Tell someone You look great! even though theyre feeling terrible, so theyll actually start looking and feeling better).

d. Brahmacharyalooking upon everything as a manifestation of Consciousness, and not just as the crude form (the holistic approachwere not just bodies and chemicals).

e. Aparigrahanon-indulgence in those material amenities that are superfluous to the maintenance of life (with due regard to the prevailing standard of living in the society at large).

2. NIYAMA (extro-internal observances)

a. Shaochapurity and cleanliness, mental and physical (wash your hands often. Wash your mind often too).

b. Santoshacontentedness with the fruits of reasonable labor (no more 80-hour work weeks, if we can help it).

c. Tapahwillingly undergoing pain for the benefit of others. Service without thought of reward, just because you recognize the Supreme in the object of your service (we all do indigent care, at home or abroad).

d. Svadhyayascriptural study with a view to understanding the underlying meaning (read your journals).

e. Iishvarah Pranidhanachasing the Supremeestablishing oneself in the Cosmic Shelter; looking upon oneself as the instrument rather than as the doer (I will lead my life and practice my art in purity and holiness Hippocratic Oath).

Yoga requires balance in the mind, body, and spirit. But where do emotions come in? Emotions are just thoughts with enough power to stimulate hormonal and physiologic reactions. Yoga deals with these directly. Heres how:

Image removed.ASANASyoga postures

1. Asanas balance out the hormones. Dont ask me howyou just have to experience it. Theres been no convincing scientific data that Ive seen to show that cortisol or thyroid levels go anywhere predictably. Thats probably partly because people doing different studies use different techniques and yoga postures, of which there are thousands. One way that asanas work is by pressing on chakras. These are psycho-physical plexi corresponding to various points in the body. Known for thousands of years, they also correspond to conjunctions of voluntary and involuntary sphincters, sympathetic and parasympathetic nervous plexi, and major endocrine glands. The yogic description of the chakras and nervous system also looks just like a common rendition of the caduceus (see diagrams 1, 2).

2. Muscles get stretched out and utilized in a way that tones them and doesnt fatigue them terribly much. An overall sense of euphoria develops. Stretched muscles work better and with less effort. The day flows smoother.

3. Self-massage following asana practice causes release of immune modulators from the skin. Feels great, too.

4. Corpse pose, everybodys favorite, allows total release from stress, and is the basis for the Jacobson desensitization technique. You can do it at lunch for a few minutes after youve been on call the night before. Works well.

PRANAYAMABreath and energy control

With the help of asanas, and certain specific breathing exercises (slow breaths at 1-2 times/minute, or alternate-nostril breathing) one gains control over the physiology of breathing. This enhances lymphatic flow (the lungs and diaphragm are the main pump to get lymph flowing from the rest of the body into the thoracic duct) and thereby the immune system. It also calms the nerves and emotions. By breathing more slowly, habitually and consciously, ones stress reactions are diminished. Have you ever noticed that tachypnea causes anxiety? Hence the morphine used in terminal care. Yogis use endorphins instead. When youre tired or tensed in the office, a few deep breaths will help put you at ease.

PRATYAHARAWithdrawal of the attention from the sense-objects

Meditation is the practice that convincingly alters the mind in a very quick and reproducible fashion. Brain waves synchronize, various parts of the cerebral cortex are activated while others are deactivated, and a sense of bliss ensues fairly reliably. This, of course, depends on disconnecting the flow of constant stimulus from the outside world. When you get pretty good at this, intuition develops. Do this twice a day, preferably before eating, but anytime is okay.


With practice, the mind becomes steady. Use of a mantra (Baba Nam Kevalam is onemeans Only the Name of the Beloved), or focusing on the breath, or counting OM one, OM two, or staring at a candle or a blank wall, or reciting Ave Maria, all of these work for some people. Try your own. Youll find it amazing that you have so much thought in your head that you cant clear out initially. But after a while, you do. Youll feel great, and it even lasts throughout the day. Make sure you sit up straight (in a chair if you do TM or Kabala style, or on the floor like a yogi. Pillows and back supports are allowed).


Once your concentration becomes good, you really start to enter the realm of bliss, where your mind flows like oil or honey from a pot.


At this point, youve abandoned your concept of self and merged it into the Selfthe object of your concentration and meditation. Then you realize that the Self has really been meditating on you the whole time. This unity is really transcendent, and transmits unconsciously to all your patients and all those around you.

Having said and done all that, theres still a need to achieve and maintain balance in the society. So, heres a tip from Tony Robbins: make a wheel, with spokes, each arc of which represents a segment of your life. Then fill them up to the level at which each segment is functioning at this very moment in time. Are they equal? Then your wheel of life is going smoothly, and can go around very fast. Are they unequal? Then your wheel of life is going to go bump-bump-bump down the road and be very uncomfortable. So now you know which portions of your life you need to concentrate on and improve (see diagram 3).

Another critical point: How do you know when to use intuition and when to use intellect? When do you listen to that still, small voice? The answer is that you listen to it all the time, and obey it when you can. You learn to combine its wisdom with the practicality of the intellect and science that youve been taught, and youll find that it works wonderfully well.

Last point: Always see the bright side of everything, and focus on it. By worrying constantly about bad outcomes, youll bring them about. By focusing on the good outcomes and how youll make them happen, youll discover ways of bringing that about, too. You always have the choice. And as my guru, Shrii Shrii Anandamurti, told me, Forget all past mistakes. Live your life afresh from this very moment. Do something concrete for the suffering humanity. And smile a little bit! And with that, he took his hands and made my lips smile a little bit. And so you do, too.

More here:
A Physicians Guide to Balance: Yoga will save the WorldIf only People do it - APN News

Breakthrough Acoustic Therapy Device to Transform Health and Wellness – Press Release – Digital Journal

Posted: at 7:49 am

BELLEVUE, WA - October 9, 2020 - Pain, Anxiety, depression and other stress-related illnesses have become an epidemic and further weakens the immune system. Additional amplifiers such as the advent of Covid-19 and other contagions combined with poor diets, mental stress, and environmental factors have thrown many lives completely out of coherence and balance. A new product entering the market merges cutting edge technology, science, and holistic medicine to provide substantial relief for those affected - Introducing VIVRE by HI Viber, LLC.

The Vivre device is placed directly on the body to deliver specificity developed programmed acoustic frequencies providing a safe, drug and chemical free solution to a wide range of ailments and issues. The integrated audio jacks allow the user to hear as well as feel the vibration depending on the selected program, driving an immersive healing experience.

Vivre fits in the palm of the hands to target areas on the body with precision, flexibility and support where it usespatent pending Poly-Pulsemulti-channel signaling for deep cellular effects. Connected via Bluetooth to the free companion app V-Resonator, Vivre plays vibrational frequencies programs composed to treat a specific issue - entraining the body thru resonance to regain homeostasis.

Vivre is a break-thru delivery system to administer a scientifically proven, FDA Approved alternative therapy that has been proven to provide relief for decades explained Vivre creator Joel Johanneson. We designed the Vivre to work seamlessly with the V-Resonator app. The app makes it easy to select the appropriate program treating a wide range of issues for the entire family.

The Vivre is available at: http://www.vivreforhealing.com

For further information or PR enquiries, contact: Joel Johanneson, Marketing and PR, at 425-894-9279 & joel@hiviber.com

About Hi Viber, LLC:

Hi Viber, LLC, was established in 2019, is an innovative company that focuses on breakthrough products and methodologies to establish and maintain wellness to all living beings.

Media ContactCompany Name: Hi Viber, LLCContact Person: Joel JohannesonEmail: Send EmailPhone: 425.894.9279Country: United StatesWebsite: https://www.vivreforlife.com

Original post:
Breakthrough Acoustic Therapy Device to Transform Health and Wellness - Press Release - Digital Journal

GLOW Natural Wellness Creates Free Online Resource To Promote Healing At Home And Managing Chronic Disease During Pandemic – PR Web

Posted: at 7:49 am

NEW YORK (PRWEB) October 08, 2020

With the health of every American being a consistent topic of conversation, and rightfully so, it has become more important than ever for individuals to be equipped with the knowledge necessary to protect themselves and their loved ones from everyday diseases and ailments. In an effort to provide the resources and information that will create informed citizens who are taking control of their health, Dr. Michelle Sands, licensed Naturopathic Physician (ND) and Co-Founder of GLOW Natural Wellness will launch Natural Medicine at Home, the free online series that focuses on making health building tools, foundational skills, and healthy lifestyle protocols accessible and affordable for all people. The virtual event goes live October 18, 2020 until October 18, 2020 but participants can take advantage of early admission now and be granted access to several of the talks, the meal plan and a host of health building resources.

As the author of the internationally best-selling book, "Hormone Harmony Over 35: A New, Natural, Whole-Body Approach to Limitless Female Health, Dr. Sands is excited to utilizing her expertise in womens and metabolic health, autoimmunity conditions and genetics to help those in need. These natural medicine techniques will help both women and men that are looking to learn affordable accessible at home health building tools and techniques to help them combat chronic disease, fortify their immune health and live healthier. Each day of the seven day long immersive event will provide the platform for Dr. Sands to teach participants how to use natural medicine safely and effectively in the privacy of their own homes, with the purpose of overcoming the various medical conditions that they may be enduring or subjective to. Virtual attendees will be treated to a well-defined daily schedule that is personally curated by Dr. Sands herself and will include:

"Naturopathic Physician on a mission to help Americans get healthy, right at home, says Dr. Sands. In the midst of the COVID pandemic, we are seeing those with chronic health conditions being at an inherent higher risk for illness, so it was an important mission of mine to bring together the top health and wellness experts in the world to teach Americans how to build health in a accessible and affordable way, right at home; while being free and online.

The Natural Medicine at Home program is the first step for those that are ready to take their health into their own hands and make the life changes necessary for a long and healthy life.

For additional information and to view the video trailer, list of topics, and international panel of experts please visit:


ABOUT DR. MICHELLE SANDSDr. Michelle Sands is a licensed Naturopathic Physician (ND), Co-Founder of GLOW Natural Wellness and author of the #1 Internationally best-selling book, "Hormone Harmony Over 35: A New, Natural, Whole-Body Approach to Limitless Female Health". She is a highly sought-after Female Hormone and Epigenetics Expert specializing in womens health, holistic fertility treatments and autoimmune conditions. Dr. Michelle, her book and resulting programs, have been featured on various platforms including ABC, CBS, Outside Magazine, The Boston Herald, NBC, Fox News, and USA Today to name a select few. Her groundbreaking program, "DNA Made Simple" takes away the confusion around genetics and epigenetics and gives people a personal, scientifically supported instruction manual for optimal health. She uses data driven science, holistic lifestyle medicine, natural supplementation, epigenetic coaching, and eastern philosophies to pinpoint the source of various chronic conditions and as a result helps patients restore their overall health and increase vital energy. Dr. Michelle is also a Board-Certified Holistic Nutritionist, Certified Personal Trainer and award-winning endurance athlete.

Share article on social media or email:

See the original post:
GLOW Natural Wellness Creates Free Online Resource To Promote Healing At Home And Managing Chronic Disease During Pandemic - PR Web

Anxiety doesn’t have to be the new normal. Read on for surprisingly easy ways to find a little bit of calm. – Pacific Northwest Inlander

Posted: at 7:49 am

A lmost everyone carries with them a certain level of anxiety, whether it's concern for health, stress relating to a job, or worry over personal safety. And that was before 2020. It's an understatement to say that anxiety levels have been increasing due to the pandemic and the many social and political conflicts that have arisen over the past few months.

While it may seem overwhelming, the good news is that we're not alone, and there are things we can do to help ourselves and others work to overcome those feelings of anxiousness.

Anne Browning is a professor and assistant dean of well being for the University of Washington's School of Medicine. She is also one of the founders of the university's Resilience Lab, which aims to support instructors in creating learning environments that promote student mental health and well being.

"The idea of resilience is our ability to recover quickly from difficulties we're facing," Browning says. "At the Resilience Lab we work to give students the tools to navigate challenges and move ahead despite fears or the occasional failure."

This past May, Browning gave a webinar that talked about using resilience techniques to cope with and navigate changes brought about by the coronavirus, a topic she's still actively discussing today.

"It was, and unfortunately still is, a good time to talk about it," she says. "A lot of the anxiety in the air right now is that anticipatory fear, the not-knowing of what's next, and coping with uncertainty is something we all need to be able to do."

While most people view anxiety as a bad thing, Browning says it's important to understand that it's also a useful emotion.

"Anxiety is that voice in the back of your head that keeps you vigilant, aware of your surroundings and able to make decisions to mitigate your risk in any given situation," she says. "During the pandemic that voice might remind us to use sanitizer, stop touching our face mask, stay 6 feet apart, etc."

However, a key part of managing anxiety she says, is recognizing when that healthy vigilance tips toward overestimating the risks in our environment.

"With healthy anxiety, we're able to feel that fear and do what we can to mitigate potential risks," she says. "But people with overwhelming anxiety will overestimate the risk while underestimating what they can do to mitigate it."

"For instance, with the pandemic we've learned that with tools like masks, good hygiene, and distancing we can move about pretty safely," she says. "However, for those with overwhelming anxiety those safety tools aren't enough, and so they stay home."

Because anxiety is so overwhelming, Browning says it's important to keep engaging with those who are struggling.

"We can help anxious friends by getting them to recognize when those overwhelming feelings start, and encouraging them to reevaluate what the risks are and what they can realistically do to mitigate those risks," she says.

If you find it a struggle to quiet anxious thoughts, Browning suggests starting small, by taking a moment to yourself to acknowledge that there are things outside your control.

"You have to make peace with that idea," she says. "Once you've acknowledged that, the next step is to let yourself grieve the loss of plans, things you'd hoped to do, etc. Then lastly, allow yourself to let go of the worry over those things."

For specific situations or scenarios that trigger anxiety, Browning says it can help to focus on your own risk tolerance and what you can do to reduce your anxiety.

A good first step to countering anxiety, says UW Medicine's Anne Browning, is to acknowledge there are things outside your control.

"If for example you're struggling with crowded spaces, look at visiting earlier or later, maintaining social distancing, or leaving when it's too much," she says. "Remember that we can only control ourselves, so try not to be frustrated or angry if others appear to have a higher risk tolerance than you."

While social distancing can make it difficult to stay in touch, Browning also encourages maintaining relationships and connections.

"Seek out tools for staying in touch, or meeting up while maintaining distance," she says. "Try not to allow yourself to ruminate on negative thoughts, instead focus on what you're grateful for, or bright spots on the horizon, because recognizing those things gives you time to recover and experience resilience."


Spokane-based alternative and holistic therapist Mary Willard shares Browning's view of anxiety being linked to lack of control and uncertainty for the future.

"That's why you'll find a lot of anxiety-reducing techniques are about bringing the individuals back to the current moment," she says. "It's about refocusing, and reminding yourself that you're OK right now."

Willard holds an undergraduate degree in counseling and human resources, as well as certifications in emotional freedom techniques (also known as EFT or "tapping"), clinical and medical hypnotherapy. She is also a Simply Being meditation coach, a licensed massage therapist and a reiki master.

"Much of what I do is helping individuals to create internal structures, tools that help them to deal with life circumstances," she says.

Some tips experts often recommend for those struggling with moments of overwhelming anxiety include: taking calming breaths, slowly tensing and relaxing various muscle groups, "anchoring" yourself by focusing on sights or sounds in your immediate surroundings, and cooling off by submerging your face in cold water or holding a cold pack over your eyes.

EASE UPActivities that can help lessen anxiousness:

These techniques are suggested because they're known to reduce your heart rate and relax your body, bringing feelings of anxiousness back down to manageable levels.

Willard says an EFT or tapping, while a slightly lesser-known technique, is also highly effective in relieving anxiety and depression.

"Most of my clients after their first session describe feelings of hope, or a burden being lifted," she says. "It's amazing how quickly it's able to shift your emotional learning and bring you comfort and support."

Willard says "tapping" is rooted in the same techniques as acupuncture, a traditional Chinese medicine in which thin needles are inserted into the body at specific points with the intention of balancing physical and emotional energy pathways.

"Tapping is like acupuncture but rather than needles, you use your fingertips," she says. "When we tap we focus on the pain or emotional issue that's front and center for you, and as you go along the blocked energy at the cause of that issue is released, bringing your body back into balance."

She says tapping relieves anxiety by interrupting and eventually erasing the conditioned response we have to fears, allowing us to disengage with the triggers that usually lead to becoming upset.

"Studies have shown tapping is effective because it works with the amygdala, the part of the brain that governs our fight or flight response," she says. "When our fear response is triggered, we're setting up to deal with that threat and our cortisol (stress hormone) levels rise. That's OK initially, but when it's constant it wears on the body. Tapping has been shown to drop cortisol levels, and bring down anxiousness."

While it might seem complicated, Willard says you don't need a professional to try tapping for yourself.

"There are many resources online such as emofree.com, a book called The Tapping Solution, and countless videos and CDs that will walk you through the basics," she says. "It's a pretty forgiving process, in that even if you're not doing it perfectly, it will still help."

If you're planning to try tapping yourself at home, Willard suggests being vigilant in tapping several times a day, even when you're not anxious, so that when those anxious feelings come you're already calmer and centered.

"Keep in mind you may have to tap on an issue several times before it's resolved, as some issues are more complex," she says. "If you're feeling overwhelmed definitely consider consulting with a professional."


If you're looking for techniques other than "tapping" that might help reduce anxiety, Willard suggests tactile artistic hobbies such as finger painting or chalk drawing.

"It doesn't have to be a masterpiece, just as long as it's something you can feel," she says. "That sense of touch brings us into the present moment, helps us recognize what we need to hold onto and what we should let go of because we can't control it."

Willard also suggests getting out into nature, whether it's sitting under a tree in your backyard or walking one of the local trails.

"You don't have to do much, simply observe things like light in the leaves, scents in the air, birdsong, all of these help decrease stress hormone production and lower heart rate," she says. "Animals can also be pleasant and calming companions, so consider walking a dog, or visiting a shelter."

Spending time with a four-legged friend can help ease anxiety.

Looking ahead, both Willard and Browning say it will be important for all of us to find ways to combat the fatigue that can set in from battling uncertainty on a daily basis.

"Going forward we need to find ways of refocusing on things we can control, and fostering attitudes of positivity," Willard says.

She says taking time each day to express gratitude aloud for good things in your life, and calling friends more often to check in, are a good start.

"When we recognize and express gratitude for the good things in our life we shift our focus from the negative," she says. "Similarly, catching up with friends allows you to feel less isolated, and allows you to empathize and support one another."

Browning agrees, saying she would encourage people to check in on friends, family, and neighbors, and help them find local support if they're struggling. "At the same time, we need to be treating ourselves with compassion and kindness too. Remember this is a moment of global change that will impact all of us, so the focus needs to be on our collective well-being."

TRY THIS When you're feeling overwhelmed by feelings of anxiousness...

View post:
Anxiety doesn't have to be the new normal. Read on for surprisingly easy ways to find a little bit of calm. - Pacific Northwest Inlander

« Previous Post  Next Posts »

Page 21234..1020..»